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 Metabolic flexibility is critical for muscle to maintain proper function and 
overall health. Muscle adapts to metabolic stress with increasing ATP synthesis by 
enhancing the rate of glycolysis and mitochondrial respiration. The control of that rate is 
mediated by several glucose metabolites. This project is based on the conceptual model 
that AMP indicates the balance of ATP synthesis and degradation, and NADH indicates 
the balance of glucose delivery to oxygen delivery. AMP signaling facilitates all aspects 
of glucose metabolism, and NAD
+
 signaling facilitates oxidative metabolism and 
inhibits reductive metabolism. The overall hypothesis is that the distribution of glucose 
depends on AMP and NAD
+
 generated during energetic stress.  
 The results suggest that glucose metabolism is highly sensitive to ATP 
homeostasis via AMPK activity. NADH oxidation alone is not sufficient to influence 
glucose oxidation, but require co-activation of AMPK. AMP and NAD
+
 signaling work 
independently in metabolic gene expression. The overall conclusion is that glucose 
metabolism depends on AMP signaling, but NAD signaling is unable to alter glucose 
disposal. AMP and NAD independently induced metabolic and differentiation 
adaptation. These findings suggest that other molecule may represent an additional 









1.1 Contractile activity imposes great metabolic load  
 Muscle contractile function requires the coordinated activity of membrane 
excitation, excitation-contraction coupling, contraction, and energy supply. Transmission 
of the signal from motor neuron into muscle fiber initiates contraction. Ca
2+
 is released 
from sarcoplasmic reticulum (SR), the intracellular storage site, to trigger the contractile 
response and sequestered by the sarcoplasmic/endoplasmic reticulum Ca
2+
-ATPase 
(SERCA) pumps to permit relaxation (Maclntosh et al., 2005). 
 During exercise, intramuscular oxygen consumption and local blood flow 
increases. Glucose delivery, transport and metabolism are up-regulated in response to 
increasing ATP turnover. ATP consumption during muscle contraction dominantly comes 




 exchange and 
SERCA for ionic transport (Schiaffino and Reggiani, 2011). The intracellular store of 
ATP is small, around 1-10 mM (Beis and Newsholme, 1975), but ATP concentration 
rarely declines below 50% of rest values (Hochachka and Matheson, 1992). During 
muscle contraction, the rate of ATP turnover can increase 500-fold or more. For example, 
ATP turnover rate in human muscle at rest is between 0.004 and 0.008 mM/s in hand and 
leg muscles (Amara et al., 2007). ATP turnover rate in human anterior tibialis and vastus 
lateralis  muscle increased to 2.45mM/s (Jones et al., 2009) and 6-9 mM/s (Jacobs et al., 
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1982) during muscle contraction. To facilitate such huge variations in ATP consumption, 
fast and efficient mechanisms of ATP resynthesis are needed. 
1.1.1 Metabolic pathways  
 Energy for contraction comes from phosphocreatine (PCr)-creatine kinase (CK) 
system, glycolysis, and mitochondrial respiration (Lanza et al., 2005). For relatively brief 
periods of activity, skeletal muscle is able to renew it supply of ATP from PCr. The PCr-
CK system dominates the total ATP regeneration during 5 to 6 seconds duration of 
maximal exercise and it is localized close to the sites of ATP consumption (Greenhaff et 
al., 1994). PCr exists in the resting muscle at four times the concentration of ATP and 
serves as a high-energy phosphate reservoir for the rapid regeneration of ATP. 
(McMahon and Jenkins, 2002).  
 Glycolysis is the stepwise degradation of glucose and is the major source of 
metabolic energy for exercise longer than a few seconds. Glycolysis can be separated into 
two phases. Phase I involves hexose phosphates and ATP consumption in each of the 
hexokinase (HK) and phosphofrucktokinase (PFK) reactions. In phase II, fructose 1,6-
biphosphate is broken to yield dihydroxyacetone phosphate and glyceraldehydes 3-
phosphate. The dihydroxyacetone phosphate is rapidly converted to glyceraldehyde 3-
phosphate by triosephosphate isomerase. Two molecules of glyceraldehyde 3-phosphate 
then follow the same pathway in the second phase of glycolysis. The net reaction for the 
overall process generates two molecules of pyruvate, two molecules of NADH, and two 
ATP (Ortenblad and Nielsen, 2015). The equilibrium constants for HK, PFK and 
pyruvate kinase (PK) in skeletal muscle are much larger than the mass action ratios 
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suggesting that HK, PFK and PK are the rate limiting steps in the glycolysis (Beatty et 
al., 1976). Furthermore, these three kinases are all subject to allosteric regulation that 
controls the flow of carbon through the pathway and maintains constant levels of 
metabolic intermediates (Beatty et al., 1976).   
 In the presence of sufficient oxygen, pyruvate from glycolysis provides acetyl 
CoA for mitochondrial oxidative phosphorylation (Dashty, 2013). Each acetyl CoA from 
glycolysis or β-oxidation can generate 18 ATP with a consumption of oxygen in a 
ATP/O2 ratio of 2.6 (Schiaffino and Reggiani, 2011). Mitochondria oxidize acetyl CoA to 
carbon dioxide during TCA cycle and generate reducing equivalents in the form of 
NADH and FADH2. The electrons produced from the oxidation of NADH and FADH2 
flow through the electron transport chain (ETC), which contains four distinct protein 
complexes in the mitochondrial inner membrane and two mobile electron carriers- 
coenzyme Q and cytochrome c. The ETC reoxidizes NADH and FADH2 from the TCA 
cycle and the liberated electrons move from a negative to a positive reduction potential 
along the complex until molecular oxygen is reduced to water. Oxygen molecules 
undergo one-or two-electron reduction reaction to form O2. or H2O2 during aerobic 
respiration. A previous study has shown that mitochondrial complex I and III are the 
primary source of ROS production (St-Pierre et al., 2002). The ETC transports protons 
from the matrix to the cytosolic side of the inner membrane, and the ATP synthase 
utilizes the resulting proton gradient to produce ATP from inorganic phosphate (Pi) and 
ADP (Dashty, 2013). The capacity of oxidative respiration is largely limited by 
mitochondrial content and oxygen delivery (Jackman and Willis, 1996; Katz and Sahlin, 
1987). Due to the long-range of electron transfer within mitochondria, the migration and 
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redox state of cytochrome c may also limit ETC activity (Mathai et al., 1993; Volkov and 
van Nuland, 2012).  
1.1.2 Redox state 
 The redox state of muscle is critically dependent on the oxidation of glucose to 
CO2. NAD is a ubiquitous cellular coenzyme acting as a carrier of electrons and 
transferring it from one molecular to another. NAD
+
/NADH redox pair regulates flux 
through glycolysis, TCA cycle, and mitochondrial ETC. In glycolysis, NADH is 
generated via glyceraldehydes 3-phosphate dehydrogenase (GAPDH) by the conversion 
of glyceraldehyde 3-phosphate to glycerate 1,3-bisphosphate. NADH is reoxidized via 
lactate dehydrogenase (LDH) during the reduction of pyruvate to lactate. The coordinated 
flux through GAPDH and LDH continually regenerates NAD
+
, thereby ensuring 
glycolytic flux (Ussher et al., 2012; Ying, 2008). Under oxidizing conditions, pyruvate is 
further metabolized by the mitochondria. Pyruvate dehydrogenase complex (PDH) 
catalyzes the conversion of pyruvate to acetyl CoA. Because NADH cannot freely cross 
the inner mitochondrial membrane, malate dehydrogenase and glycerol 3-phosphate 
shuttles are necessary for transporting NADH produced during glycolysis into 
mitochondria and subsequently regenerating cytosolic NAD
+
 (McKenna et al., 2006). In 
the TCA cycle, acetyl CoA is oxidized by several NAD
+
/NADH enzymes to generate 
NADH. These enzymes include isocitrate dehydrogenase, α-ketoglutarate dehydrogenase, 
and malate dehydrogenase coupling the oxidation of isocitrate, α-ketoglutarate, and 
malate, respectively, to the generation of NADH (Ussher et al., 2012). In mitochondrial 
ETC, the oxidation of NADH occurs at complex I and is coupled to the reduction of lipid 
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soluble ubiquinone, and the translocation of four protons per pair of electrons is 
transferred. The proton gradient across the inner mitochondrial membrane provides the 
potential energy to drive the synthesis of ATP via ATP synthase (Dashty, 2013). 
Numerous processes in glucose metabolism are influenced either directly or indirectly by 
the NAD
+
/NADH. Therefore, disturbances or dysregulation of the redox state are likely 
to affect energy homeostasis and plasticity in the muscle and the decrease in the ratio of 
NAD
+
/NADH is associated with diabetes-related alternations (Ido, 2007). 
1.1.3 Phenotypic specialization 
 Skeletal muscle is a dynamic tissue with considerable specialization depending on 
use. There are three major muscle types (one slow and two fast) in human body. Type 1 
(slow twitch), type 2A, and type 2X (fast witch) fibers are known to contain different 
myosin heavy chain (MyHC) composition, which are responsible for their different 
myosin ATPase activity (Han et al., 2003; He et al., 2000), and speed of shortening 
(Weiss et al., 2001).  
 ATPase activity in slow fibers was considerably low (0.045 mM/s) (Bottinelli et 
al., 1994). The amount of ATP consumed per unit tension is lower in slow (0.66 mM/N/s) 






), thus making slow fibers 
suitable for maintaining tension in postural activity (Bottinelli et al., 1994). Slow fibers 
rely predominantly on the oxidative pathway, but fast fibers are specialized for rapid, 
anaerobic ATP synthesis. ATP generation based on glycolysis has been calculated to be 
2.5mM/s in fast and 1.2 mM/s in slow fibers (Greenhaff et al., 1993). Fast muscle fibers 
(2A, 2X) depend mainly on glucose oxidation and anaerobic glycolysis, respectively 
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(Schiaffino and Reggiani, 2011). ATPase activity was significantly higher in 2X and 2A 
fibers (0.178 and 0.168 mM/s, respectively). In addition, the level of fructose-2,-6-
biphosphate, a potent activator of PFK, is higher in fast fiber (Hers, 1984). Furthermore, 
higher LDH activity ( 9-10 times) in fast fibers allows the rapid accumulation of pyruvate 
with concomitant degradation of NADH (Lowry et al., 1978).  
 ATP generation through TCA cycle is more effective in slow than in fast fibers 
due to greater mitochondrial density and greater TCA cycle fueling due to β-oxidation. In 
human muscle, the mitochondrial volume is higher in slow fibers than in fast fibers (type 
1:6%, type 2A: 4.5%, type 2X:2.3%) (Howald et al., 1985). The maximum oxygen 
consumption rate in rat soleus versus gastrocnemius is 48µM/s versus 22µM/s 
(Kuznetsov et al., 1996). Such values are in proportion to their mitochondrial volume, 
citric enzyme activity and electron transport chain capacity which are two fold higher in 
slow fiber (Jackman and Willis, 1996). Pyruvate dehydrogenase kinase (PDK) activity is 
three times lower in slow fiber than in fast fiber (Peters et al., 2001). These observations 
suggest that slow and fast muscles differ in the relative role of glycolysis and oxidative 
phosphorylation and this metabolic diversity of muscle fibers contributes to their ability 
to maintain contractile activity. In this project, my interest is primarily in the regulation 




1.2 Response to contractile activity  
1.2.1 Immediate metabolic perturbation 
 Under physiological conditions, ATP concentration changes little because ATP 
production is immediately accelerated to cover the ATP consuming processes. Following 
a 30-second sprint, PCr and ATP concentration in vastus lateralis muscle reduced from 
resting values of 83.9 and 23.9 mmole/kg dry muscle (dm) to 34.8 and 18.7 mmole/kg 
dm and a further decline was reported to 24.2 and 17.3 mmole/kg dm after the second 
sprint (Casey et al., 1996). Although PCr had fallen by 71% of resting values, ATP fell 
by only 28% after second sprint. The relative changes in AMP are much greater than 
those occur in ATP. For example, after high intensity exercise, ATP only drops 37% 
(Cheetham et al., 1986), but AMP can increase from nanomole to micromole (Crowther 
et al., 2002). 
  Glycogen and glucose metabolism provide a second source of ATP with lower 
power but greater capacity (glycogen 300-900 mmole/kg dry muscle) compared with 
PCr-CK system (Ortenblad and Nielsen, 2015). Both PCr-CK and glycolysis system 
provide 15mM/s ATP over the first 6 seconds of exercise. Glycolysis rate does not 
achieve its maximum until 5 seconds, but PCr starts to decline at 1.6 seconds (Gastin, 
2001). After high intensity exercise, glycolytic ATP production contributes to PCr 
resynthesis during the initial stage of recovery. If PCr is not fully restored during the 
recovery phase, the performance in subsequent exercise bout may decline. Over a period 
of 30-second of exercise the contribution from glycolysis to ATP turnover is nearly 
double that of PCr. 
8 
 
 Glucose uptake, glycogenolysis, glycolysis, and mitochondrial respiration are 
increased as a consequence of muscle contraction. The glycolytic metabolites, glucose-6-
phosphate, glucose-1-phosphate and Fructose 6-phosphate increase 13, 10 and 11 fold, 
respectively. Pyruvate and lactate concentrations in muscle increase 19 and 29 fold 
during sprint running (Cheetham et al., 1986). In the cascade from glycogen to CO2, this 
represents a depletion of the input and substantial accumulation of intermediates. This 
suggests that glycolytic flux outpaces mitochondrial flux increasing ATP synthesis 
beyond the mitochondrial capacity.  
 Immediately starting exercise, an initial burst of ROS occurs, followed by 
increased scavenging. During exercise, muscle produces ROS steadily, and ROS is 
gradually accumulated (Powers et al., 2011). Oxygen delivery and mitochondrial activity 
increase during exercise. An increase of electron leak in ETC is the consequence of 
increasing ATP turnover (Ji, 2015). Another source of physiological ROS in the form of 
either H2O2 or O2
.
 is NADPH oxidases (NOX). Although NOX has been shown to 
produce ROS during muscle contraction (Prosser et al., 2011), NOX produced ROS are 
most described in the context of neutrophils for the phagocytic killing of pathogens 
during the immune response (Lassegue et al., 2012). Mitochondria and the NOX family 
are the best characterized intracellular source of ROS, but other enzymes, such as 
xanthine oxidase, cyclooxygenases and lipoxygenases can all produce ROS during 
muscle contraction (Holmstrom and Finkel, 2014). 
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1.2.2 Functional accommodation 
1.2.2.1 Glucose uptake 
The increase in glucose uptake parallels the increase in exercise intensity and 
duration. After 35 min cycling at 30%, 55%, and 75% VO2max, glucose uptake in 
quardricep femoris muscle increased 5 fold, 11fold ,and  15fold, respectively 
(Kemppainen et al., 2002). During 40min cycling at 50% VO2max, leg glucose uptake 
increased 5.5 fold at 15min and 11.1 fold at 40min (Hargreaves et al., 1992), but muscle 
glycogen decreased 21% at 15min and 37% at 40min. These results suggest that glucose 
uptake increases in the proportion of exercise intensity and glycogen depletion. 
 Because glucose cannot freely cross plasma membrane, carrier mediated 
transporters are required to facilitate entry of glucose into muscle cell. Previous studies 
have suggested that glucose uptake initiated by insulin or energetic stress involves the 
translocation of glucose transporters from intracellular reserves and their subsequent 
insertion into the plasma membrane (Michelle Furtado et al., 2003). To date, 14 different 
isoforms of glucose transporter have been identified, and GLUT1 and GLUT4 are 
expressed most abundantly in skeletal muscle (Mitsumoto et al., 1991; Thorens and 
Mueckler, 2010). Insulin and muscle contraction increase glucose uptake by translocation 
of GLUT4. Insulin signaling involves rapid phosphorylation of the insulin receptor and 
the activation of the phosphatidylinositol 3-kinase and Akt. Insulin-induced Akt 
activation promotes GLUT4 exocytosis by phosphorylating the Akt substrate of TBC1D4 
and TBC1D1 (Kramer et al., 2006; Middelbeek et al., 2013). Exercise enhances muscle 
glucose uptake through an insulin-independent mechanism that involves the increasing of 
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metabolic activity (Hayashi et al., 1998). Contraction-stimulated GLUT4 is independent 
of insulin receptor substrate-1 (IRS1) and Akt (Kramer et al., 2006; Wojtaszewski et al., 
1999). It has been suggested that insulin- and contraction-stimulated glucose uptake may 
converge signaling in TBC1D4, TBC1D1 as well as GLUT4 translocation (An et al., 
2010; Kramer et al., 2006). These observations suggest that one mechanism to increase 
glucose uptake is by Akt/AMPK transport of GLUT4. It is not clear whether GLUT4 
translocation is the sole mechanism for the increase in glucose transport during exercise. 
Clone 9 cells only express GLUT1, but not GLUT4. SB203580, a p38 inhibitor, blocks 
AICAR-induced glucose uptake in clone 9 cells (Xi et al., 2001). Aim 1 is based on the 
possibility that p38 might be important for glucose uptake. 
1.2.2.2 Glycolytic adaptation 
In resting cells, glucose uptake appears to be limited by the availability of glucose 
transporters, but stimulation by contraction may shift the rate-limiting process 
downstream (Fueger et al., 2004; Fueger et al., 2005). This means that peak glucose 
uptake will be strongly influenced by glucose disposal. HK, PFK, and pyruvate kinase are 
all subject to allosteric regulation that controls the flow of carbon through the pathway. 
For example, muscle contraction causes ATP depletion, and ADP, AMP accumulation 
which significantly enhances PFK activity through allosteric regulation (Kemp and 
Gunasekera, 2002; Krause and Wegener, 1996; Schmitz et al., 2013). A computer model 
of glycolysis in skeletal muscle estimates that PFK activity increases 91fold with 5 fold 
increase in ADP during rest-to-intensive work transition (Liguzinski and Korzeniewski, 
2006). At 250% VO2 max cycling for 30 sec, PFK activity is 50-70 fold higher than 35% 
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VO2 max (Spriet et al., 2000).These observations suggest that accumulation of ADP 
facilitates glycolysis by allosteric regulation. The accumulation of AMP increases 
glucose uptake through AMPK activation, but the extent to which AMPK-mediated 
increase in glucose uptake reflects mass action or post-translational modification is not 
clear. 
1.2.2.3 Pyruvate disposal 
Pyruvate stands at a metabolic crossroad between aerobic and anaerobic 
metabolism. The ability of muscle cells to switch between pyruvate reduction and 
oxidation may be determined by the ratio of NAD
+
/NADH. NADH content and lactate 
production depend on exercise intensity (fig. 1-1 below). After an initial decrease to 60%  
of resting NADH at 40%VO2 max, NADH increases with intensity, eventually reaching 
160% of control at 100%VO2 max (Sahlin et al., 1987). It is possible that at low intensity 
(40% VO2 max), enzymatic activity within the mitochondria increases, depleting high-
energy NADH, resulting in no change in lactate production. At high intensity (100% VO2 
max), the resulting NADH production from glycolysis is accumulated and lactate 
production increases by 11 fold via LDH (Sahlin et al., 1990; Spriet et al., 2000). This 
suggests that the oxidation state of mitochondrial NAD reflects the balance of glycolytic 
production of pyruvate and the delivery of O2, being more oxidized (NAD
+
) when 





Figure 1-1 Glucose metabolites and PDH, LDH flux after exercise  
Muscle content of a) NADH  b) lactate, c) PDH flux, and d) LDH flux at rest and immediately after 
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 During exercise, the flux of PDH and LDH changed to different extents (fig. 1-1 
above ) (Spriet et al., 2000). PDH flux increases from 1.5 to 2.7 mmole/min during the 
transition from 35% VO2max to 65% VO2max. LDH flux is estimated around 0.75 
mmole/min at 40% VO2max. At 65% VO2max, LDH flux is increased to 5.2 mmole/min, 
which is about two fold higher than PDH. From 90% to 250% VO2max, PHD flux slowly 
increases from 3.4 to 4.5mmole/min, but LDH flux rapidly increases from 9.6 to 60 
mmole/min (Spriet et al., 2000). 
1.2.3 Long-term metabolic adaptation 
Endurance training causes a two-fold increase in the capacity of pyruvate 
oxidation in skeletal muscle. In addition, the activity of the enzymes of the mitochondrial 
electron transport chains doubles (Egan et al., 2011; Holloszy, 1967). Low intensity 
exercise stimulates mitochondrial biogenesis resulting in increased oxidative capacity and 
increased fatigue resistance (Little et al., 2010; Pilegaard et al., 2003). By contrast, high 
intensity training results in an decrease of the proportion of type 1 fibers from 57% to 
48% and an increase of type 2A fibers from 32% to 38% (Jansson et al., 1990). CK, PFK, 
glycogen phosphorylase, LDH activity have been shown to increase after sprint training 
(Linossier et al., 1997; Thorstensson et al., 1975). Exercise changes intracellular 
metabolic profile rapidly and drastically suggesting that some key metabolite-protein 
interactions may mediate long term adaptation. The energy status (AMP) and oxidative 
status (NAD
+
) may provide a stimulus for coherent conversion between glycolytic and 
oxidative phenotypes. For example, low intensity exercise is characterized by 





High intensity exercise is associated with workloads in excess of 60-70% VO2max, 
anaerobic conditions, and net reduction of NAD
+
 to NADH.  
1.3 Metabolic signaling 
 Exercise-induced metabolic activity results in the perturbation of intracellular O2, 
ROS, Ca
2+
, AMP and NAD. These energetic stresses can serve as a mechanism for cells 
to reprogram their metabolism. These intracellular changes can in turn be detected by 
mitogen activated protein kinase (MAPK), AMP kinase (AMPK), and sirtuin. These 
signaling factors alter the activity of a number of transcription factors with the final result 
being a switch in protein distribution towards different phenotypes (Egan et al., 2010; 
Hoppeler et al., 2011). 
1.3.1 AMP signaling 
Dephosphorylated forms of ATP, especially, AMP, is a potent allosteric activator 
of enzymes influential to glucose metabolism, such as PFK (Schmitz et al., 2013), PDH 
and PDK (Lazo and Sols, 1980; Sugden and Holness, 2006). AMP activates PFK thereby 
allowing increased flux of hexose phosphates through glycolysis (Bruser et al., 2012). 
PDH is inhibited by PDK via phosphorylation. PDK is allosterically stimulated by ATP 
and inhibited by ADP (Bao et al., 2004a; Bao et al., 2004b).  
AMP binding to the γ-subunit can stimulate AMPK allosterically and further 
leads to increased AMPK phosphorylation which can dramatically enhance AMPK 
activity (Hardie and Ashford, 2014). AMPK is a heterotrimeric enzyme consisting a 
catalytic α-subunit (α1 or α2) in combination with a regulatory β- (β1 or β2) and γ-
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subunit (γ 1,γ2, or γ3) (Hardie, 2014). Two upstream kinases, serine-threonine liver 
kinase B1 (LKB1) and calcium/calmodulin kinase kinase-β (CaMKKβ), activate AMPK 
by phosphorylating a threonine residue (Thr172) on its catalytic α-subunit. LKB1 
catalyzes the phosphorylation in response to metabolic stress. CaMKKβ activates AMPK 
in response to increases in intracellular Ca2
+
caused by various hormones and calcium 
ionophores (Hawley et al., 2005).  
Excess amounts of ROS impair ATP synthesis leading to AMP accumulation and 
subsequent AMPK activation (Rocha et al., 2016). However, a previous study has shown 
Lkb1is required for H2O2-induced AMPK activation independent of an increase in 
AMP/ATP ratio (Emerling et al., 2009). ROS may also directly influence AMPK activity 
through oxidation of cysteine299 and cysteine304 residues (Zmijewski et al., 2010). 
These observations suggest that AMPK activation, in addition to being a response to 
alterations in intracellular metabolic pathways, is directly influenced by cellular redox 
status. 
Contraction-stimulated GLUT4 translocation is dependent on AMPK, but is 
independent of IRS1 and Akt .  Mice lacking AMPKα1/2 show significantly impaired 
contraction-stimulated glucose uptake (O'Neill, 2013; O'Neill et al., 2011). (O'Neill, 
2013). The AMPK inhibitor compound C (Funai and Cartee, 2009) and AMPK β-subunit 
knockout (O'Neill et al., 2011) have been shown to inhibit TBC1D1 phosphorylation and 
glucose uptake. Phosphorylation of three different sites (Ser237; Ser660; Thr597) of 
TBC1D1 increases with muscle contraction in an AMPK-dependent manner (Frosig et 
al., 2010; Pehmoller et al., 2009; Vichaiwong et al., 2010). These observations suggest 
that AMPK is required for contraction-stimulated GLUT4 translocation.  
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p38 MAPK has been suggested to be a downstream effector of AMPK and to 
participate in GLUT4 activation (Michelle Furtado et al., 2003; Somwar et al., 2002; 
Sweeney et al., 1999). Under metabolic stress, AMPK appears to recruit p38 to a 
transforming growth factor-beta-activated protein kinase 1-binding protein (TAB1) 
macromolecular complex, where it undergoes autophosphorylation. Activation of p38 
may be required for maximal glucose uptake in skeletal myocytes, potentially by 
activating the GLUT4 transporter after its insertion into the cell membrane (Somwar et 
al., 2001; Somwar et al., 2000). These observations suggest that AMPK-mediated glucose 
uptake may involve p38 activation. However, dissociation of signaling between AMPK 
and p38 has been reported by several studies (Chambers et al., 2009; Ho et al., 2007; 
Jacquet et al., 2007). For example, in L6 myoblasts, and myotubes and in rat EDL 
muscle, AICAR activates AMPK and increases glucose uptake without increasing p38 
phosphorylation (Ho et al., 2007). Mice deficient in AMPKα2 do not phosphorylate p38 
after muscle stretch, but p38 inhibitors SB203580 and A304000 block stretch-induced 
glucose uptake (Chambers et al., 2009). Although p38 becomes active during exercise, 
whether p38 contributes to glucose metabolism is not clear. 
There are several AMPK targets in the regulation of skeletal muscle adaptation to 
exercise (Mounier et al., 2015). AMPK phosphorylates the transcription repressor histone 
deacetylase 5 (HDAC5) following exercise. GLUT4 gene expression induced by exercise 
depends on the HDAC5 phosphorylation (McGee and Hargreaves, 2011). HDAC5 
phosphorylation prevents the formation of HDAC-MEF2 complex and activates PGC-1a 
(McKinsey et al., 2000). AMPK activation has been shown to stimulate muscle atrophy 
by phosphorylating the transcription factor forkhead box protein O3a (FoxO3a) (Gross et 
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al., 2008). Activation of FOXOs increases the expression of muscle atrophy genes in 
response to starvation (Gross et al., 2008). PDK4 mRNA and protein expression are 
enhanced by AMPK, and thus decreases glucose oxidation and increases fatty acid 
oxidation (Fritzen et al., 2015; Houten et al., 2009).  
  In short-term exercise, AMP-mediated allosteric regulation and AMPK activation 
increase glucose uptake and glycolysis. In long-term exercise, AMPK up-regulates 
glycolytic gene expression and inhibits the differentiation or growth of muscle. 
1.3.2 NAD-dependent signaling 
 PDH is a multi-enzyme complex located on the inside of the inner mitochondrial 
membrane. The activity of PDH is regulated by a variety of mechanisms: it is regulated 
by allosteric regulation by end products including acetyl CoA and NADH. PDH is also 







 (Rardin et al., 2009). PDK is activated by ATP, 
NADH and acetyl-CoA and is inhibited by ADP, NAD
+
, CoA-SH and pyruvate (Sugden 
and Holness, 2006). Because LDH is an equilibrium enzyme, increased lactate production 
will be due to a mass-action effect exerted by increases in pyruvate and NADH 
concentrations (Heigenhauser and Parolin, 1999). 
NAD not only is an essential electron carrier, but also is a substrate in protein 
deacetylation and ADP-ribosylation (Canto and Auwerx, 2012; Nikiforov et al., 2015).  
NAD
+
-dependent deacetylation is performed by silent information regulator-2 (Sir2) like 
proteins (sirtuins). Sirtuins deacetylate a broad range of protein substrates including 
histone, PGC-1α (Canto et al., 2009; Canto et al., 2010), p53 (Aksoy et al., 2006; McGee 
and Hargreaves, 2011) and FOXO (Canto et al., 2010; Hori et al., 2013) and various 
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mitochondrial proteins. Changes in intracellular NAD
+
 may fluctuate by as much as 2-
fold (Canto et al., 2009; Fulco et al., 2008; Rodgers et al., 2005). The estimated 
intracellular concentration of NAD
+
 is in the 0.2 mM to 0.5mM range, and the Km of the 
sirtuins for NAD
+
 falls into this range (Sauve et al., 2006). These observations suggest 
that sirtuin activity may be dependent on physiologically relevant changes in NAD
+
. 
SIRT1 is the most studied member of the sirtuin family. SIRT1 activity is enhanced in 
mammalian tissues in response to metabolic stress, such as exercise (Canto et al., 2009), 
fasting (Rodgers et al., 2005), or calorie restriction (Chen et al., 2008), all conditions 
under which NAD
+
 is elevated. This suggests that SIRT1 activity is linked to glucose 
metabolism and may regulate the cellular response to the environmental signals. 
 SIRT1 signaling may have a powerful influence on skeletal muscle performance 
and adaptation. SIRT1 deacetylates and positively regulates the activity of PGC-1α, a 
master regulator of mitochondrial biogenesis to regulate mitochondrial function (Canto et 
al., 2010; Rodgers et al., 2005). Nicotinamide riboside (NR) supplementation 
significantly increased SIRT1 activity, up-regulated PGC-1α target gene expressions, and 
improved mitochondrial function in mice (Canto et al., 2012). Treatment with the natural 
polyphenolic compound resveratrol, a SIRT1 and AMPK activator, significantly 
increased SIRT1 activity and improved mitochondrial function (Lagouge et al., 2006). 
SIRT1 also regulates differentiation of cultured skeletal muscle cells via deacetylation of 
transcription factors such as FOXO (Hori et al., 2013; Nedachi et al., 2008) and p53 
(Cheng et al., 2003; Hori et al., 2013). Mouse primary myoblasts from SIRT1 knockout 
mice were resistant to inhibition of differentiation by glucose restriction or AICAR 
(Fulco et al., 2008). This suggests that some effects attributed to AMP-induced signaling 
may be mediated by SIRT1. 
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 Another mechanism of NAD
+
-dependent signaling is ADP-ribosylation. This 
reaction is catalyzed by ADP- ribosyltransferases which transfer ADP-ribose moiety from 
NAD to specific amino acid residues on substrate proteins or to ADP-ribose itself 
(Hottiger et al., 2010). ADP-ribosylation has been shown to regulate many essential 
cellular processes including: DNA repair, apoptosis, and glycolysis (Andrabi et al., 2014; 
Hassa and Hottiger, 2008). For example, poly (ADP-ribose) polymerase-1 (PARP1) 
activation inhibited hexokinase activity by the formation of poly (ADP-ribose) in 
neurons. Overexpression of PARP1 inhibited glycolysis, while preventing PAR 
formation by PAR glycohydrolase restored the glycolysis (Fouquerel et al., 2014).  
 NADH increases in high intensity exercise and may play a central role in the 
regulation of pyruvate oxidation and reduction. NAD
+
 is increased during low-intensity 
exercise or starvation, and acts through SIRT1-mediated deacetylation to increase 
mitochondrial biogenesis and inhibits the differentiation or growth of muscle.  
1.3.3 Interaction of AMP and NAD signaling 
 AMPK and SIRT share multiple downstream substrates in ways that allow the cell 
to respond differently to modest and extreme energetic stress. AMPK induces the 
phosphorylation of many transcription factors and co-activators, including PGC-1α and 
hypoxia-Inducible Factor 1-α (HIF-1α). Both of these transcription factors are also 
regulated by SIRT1. SIRT1 represses HIF-1α target genes (Lim et al., 2010), but 
enhances PGC-1α activity (Canto et al., 2012). HIF-1α is the ‘‘master regulator’’ of cell 
hypoxic signaling. HIF-1α is stabilized during oxygen deprivation and directly involved 
in the upregulation of several glycolytic enzymes, such as glyceraldehyde-3-phosphate 
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dehydrogenase (GAPDH) and LDH (Dehne et al., 2007; Kim et al., 2006). PGC-1α is 
required for the induction of mitochondrial gene expression (Rohas et al., 2007). 
Recently, evidence suggests that AMPK can either directly phosphorylate PGC-1α or 
increase its expression, and hypoxia inhibits the PGC-1α pathway and the expression of 
mitochondrial components through HIF-1α (Slot et al., 2014). These observations suggest 
that AMPK and SIRT1 have some distinctions and similarities in their regulation on 
phenotypic adaptation. It is also conceivable that SIRT1 and AMPK may co-mediate 
signaling to regulate glucose metabolism. 
 There are two slightly antagonistic models for AMPK-SIRT1 interaction. One is 
that AMPK can function as a SIRT1 activator by the up-regulation of Nicotinamide 
phosphoribosyltransferase (nampt) gene expression and subsequent increase of NAD
+
 
(Canto et al., 2009; Fulco et al., 2008). Nampt is the rate-limiting enzyme in the salvage 
pathway of NAD biosynthesis (Revollo et al., 2004). This mechanism suggests that all of 
the signaling that seems to be AMPK mediated maybe actually dependent on SIRT1. 
Activation of AMPK by glucose restriction or AICAR treatment impaired the 
differentiation of C2C12 myoblasts (Fulco et al., 2008). The inhibition of differentiation 
was accompanied by the increase of nampt gene expression, which in turn increased the 
NAD
+
/NADH ratio. Conversely, AMPK activation has no effect on muscle 
differentiation in SIRT1 knockdown mice suggesting that SIRT1 maybe an AMPK 
downstream effector (Fulco et al., 2008).  
 Other studies proposed that AMPK could alter the NAD
+
/NADH ratio and 
activate SIRT1 independently of nampt (Canto et al., 2009; Canto et al., 2010). AICAR 
treatment for 4-12 hour increased the NAD
+
/NADH ratio in C2C12 myotubes transfected 
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with PGC-1α and enhanced PGC-1α deacetylation. However, acute blockage of nampt 
activity with the specific inhibitor FK866 did not affect AICAR’s capacity to modulate 
PGC-1α acetylation or NAD
+
/NADH ratio (Canto et al., 2009). These observations 
suggest that AMPK may act as the primordial trigger for fasting- and exercise-induced 
adaptations in skeletal muscle, and phosphorylation by AMPK might be required for 
PGC-1α deacetylation by SIRT1 and its downstream signaling. 
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1.4 Proposed model 
 
 
Figure 1-2 Proposed model 
A model characterizing AMP and NAD(H) accumulation as a function of actual metabolic rates (Lac: 
lactate, TF: transcription factor, green arrow: glucose flux, red arrow: activation signaling). AMP 
contributes to glucose uptake and glycolysis. NAD(H) contributes to the weighting of PDH/LDH. At low 
intensity exercise, AMP and NAD
+
 activate PGC-1α by AMPK-mediated phosphorylation and SIRT1-
mediated deacetylation. Activation of PGC-1α contributes to mitochondrial adaptation. At high intensity 
exercise, accumulation of NADH and low SIRT1 activity limits PGC-1α activity, and AMP increases HIF-

















































A)Rest B)Low-intensity exercise C)High-intensity exercise
23 
 
 This thesis is based on a conceptual model (fig. 1-2 above) in which AMP and 
NAD
+
 accumulate as a function of actual metabolic rates. AMP/ATP ratio influences the 
activity of enzymatic processes in glycolysis to maintain ATP homeostasis. 
NAD
+
/NADH ratio influences the balance of oxidative and anaerobic metabolism. The 
interactions of AMP and NAD
+
 signaling contribute to glycolytic and mitochondrial 
adaptation. During exercise, the accumulation of AMP due to increased ATP turnover 
may increase glucose uptake and enzyme activity within glycolysis. At low intensity 
exercise, mitochondrial respiration is stimulated by increasing oxygen delivery and 
substrate availability. The net oxidation of NADH to NAD
+
 increases. AMPK and SIRT1 
activation increases mitochondrial biogenesis by activating PGC-1α. At high intensity 
exercise, glycolysis continues to increase, but mitochondria respiration is limited by O2. 
NADH accumulates and encourages pyruvate reduction to lactate via LDH. AMPK 
activation is increased at low and high intensity exercise, but low SIRT1 activity at high 
intensity limits PGC-1α activity. Thus, the overall hypothesis is that distribution of 
glucose and mitochondrial remodeling depends on the AMP and NAD
+
 generated during 






1.5 Specific aims 
Specific Aim 1: To evaluate the contribution of AMPK and p38 to AMP-dependent 
facilitation of glycolysis. Phosphorylation of p38 coincides with increased glucose uptake, 
but the role of p38 in glucose uptake is controversial. Evidence in the literature supports a 
role of p38 MAPK in glucose transport and it may be a downstream effector of AMPK. 
However, transgenic expression of dominant-negative p38α/β isoforms has little effect on 
insulin-stimulated glucose uptake, and AICAR activates AMPK without phosphorylation 
of p38. Both ATP depletion and AICAR stimulation increase AMPK activity and glucose 
uptake, but only ATP depletion increases glycolysis, suggesting that a metabolite of 
glycolysis indirectly stimulates p38 phosphorylation. Specific aim 1 examines the role of 
AMPK and p38 in glucose metabolism during ATP depletion and to determine whether 
p38 regulates glycolytic activity or is activated as a consequence of glycolysis.  This aim 
is based on the specific hypothesis that p38 is activated by the accumulation of 
metabolites rather than controls glucose uptake during ATP depletion. 
Specific Aim 2: To evaluate the contribution of cellular redox state in the balance of 
oxidative and anaerobic metabolism. Because LDH requires NADH and PDH requires 
NAD
+
 to metabolize pyruvate, the balance of reductive and oxidative disposal of 
pyruvate depends on the redox state of NAD (within model description, fig. 1-2, above).  
However, whether oxidation of NADH is sufficient to increase pyruvate oxidation is not 
clear. Specific Aim 2 is designed to determine the weighting of AMP and NAD signaling 
in the balance of aerobic and anaerobic metabolism. This aim is based on the hypothesis 
that NADH oxidation increases glucose oxidation via both mass action and PDH 
phosphorylation.  
Specific Aim 3: To evaluate models of AMP and NAD
+
 signaling for transcriptional 
regulation of myogenic differentiation and metabolism. AMPK and SIRT1 share several 
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effector transcription factors. Controversy exists whether AMPK and SIRT1 activities are 
independent or sequential. Specific aim 3 is designed to manipulate the metabolites 
independently to test the independence of their signaling effectors. This aim is based on 
the hypothesis that AMP-dependent signaling is a necessary antecedent to deacetylation, 
but not sufficient to induce transcriptional activity. 
1.6 Experimental methods 
1.6.1 C2C12 myotubes 
 Although cell culture model does not exactly mimic human activity because of the 
absence of whole body response from different organs, it provides simplicity compared to 
the difficulties of studies using human or animal models. For example, cells are grown 
under controlled conditions, it allows us to study and interpret specific physiological 
intervention without other responses, such as nutrient availability. In this project the main 
focuses are the AMP and NAD signaling in glucose metabolism. C2C12 myotube is a 
well-defined model in glycolysis and mitochondrial respiration. It is a great model to 
study glucose and NADH oxidation because of the high glycolysis rate and low 
mitochondrial respiration. AICAR has been used to stimulate AMPK activation in C2C12 
myotubes (Canto et al., 2009; Sasaki et al., 2014). NAD precursor supplementation has 
been used to boost NAD content in skeletal muscle, liver, and brown adipose tissue 
(Canto et al., 2012). Whether systemic application of AICAR or NAD has specific action 
on muscle is not clear. The limitations of C2C12 cell line include that only 60-80% 
myoblasts fuse into myotubes, and the culture medium is not well defined as its 
physiological environment, such as high glucose concentration (culture: 25mM, human: 
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5mM), high oxygen concentration and growth factors. Although cell line is easily 
manipulated and propagated, it escapes the in vivo condition. The prediction of the 
signaling pathways from this project might need to be tested in vivo in the future. 
1.6.2 NAD supplementation 
NAD is synthesized via de novo pathway and salvage pathway. The de novo 
pathway starts with the essential amino acid L-tryptophan, which is taken up from the 
diet. Tryptophan degradation generates quinolinic acid (QA), which is converted to 
nicotinic acid mononucleotide (NAMN), an intermediate of NAD metabolism. Although 
NAD can be synthesized de novo from tryptophan, it is assumed that the main source of 
NAD is from salvage pathways using NAM as precursor (Nikiforov et al., 2015). To date, 
several methods have been shown to increase NAD content. For example, changing 
nampt activity can influence NAD content in several mammalian cells and animals 
(Frederick et al., 2015; Pittelli et al., 2010; Revollo et al., 2004). Nampt gene expression 
has been observed to increase in C2C12 myotubes in response to glucose restriction, and 
changing the nampt activity was associated with changes in SIRT1 activity (Fulco et al., 
2008). Another way to modulate NAD content resides in the modulation of the activity of 
non-sirtuin NAD consuming enzymes. Mice lacking CD38, as a main NAD consumer, 
displayed a 30-fold increase in NAD contents in the liver (Aksoy et al., 2006). Although 
this increase in NAD content is much higher than NAD precursor supplementation or 
caloric restriction, CD38 knockout mice display a severe impairment in beta-cell function 
(Antonelli and Ferrannini, 2004). Calorie restriction can boost NAD content, but this 
intervention may cause some off-target effects, such as muscle dystrophy. Studies have 
shown that supplementation with nicotinic acid (NA) (Canto et al., 2012), Nicotinamide 
mononucleotide (NMN) (Canto et al., 2012; Yamamoto et al., 2014; Yoshino et al., 2011) 
or nicotinamide riboside (NR) (Canto et al., 2012; Yang et al., 2007) increased NAD 
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content and that increase was associated with SIRT1 activation (Yamamoto et al., 2014; 
Yoshino et al., 2011). NMN was used to boost NAD content in this study. 
1.6.3 Metabolic assay 
 ATP can be measured by HPLC, but it requires specialized instrumentation. ATP 
can be measured by utilizing the phosphorylation of glycerol to generate a product that 
can be quantified by colorimetric methods, or fluorometric methods. ATP can also be 
measured by bioluminescence methods after addition of luciferin-luciferase. In this 
project, ATP concentration was measured by bioluminescence assay because it is more 
sensitive than colorimetric and fluorometric assays. Fluorescent reporters are susceptible 
to photobleaching, and cellular components may have autofluorescent properties which 
increase the non-specific background. In contrast, photon emission from bioluminescence 
assay is located within the well-protected environment of the enzymatic active site, and 
cellular components have no inherent bioluminescence.   
 Lactate can react with specific enzymes to generate a product that is easily 
measured by colorimetric and fluorometric methods. Although fluorometric assay is 
much more sensitive than colorimetric assay, extracellular lactate concentration is around 
300µM after 15min incubation. Colorimetric assay is sufficient to detect the lactate 
concentration. Therefore, colorimetric assay was used in this study. 
 NADH can be measured by colorimetric assay via monitoring of NADH 
absorption at 340nm or by fluorescence assay via monitoring of NADH auto fluorescence 
at 460nm. However, these methods suffer low sensitivity and high interference. 
Enzymatic cycling contains sample NAD and couples a cycling assay using the enzymes 
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aldehyde dehydrogenase (ADH) and diaphorase to provide an amplification of analytical 





Activation of p38 in C2C12 myotubes following ATP depletion 
depends on extracellular glucose 
 
2.1 Abstract 
 Muscle cells adjust their glucose metabolism in response to myriad stimuli, and 
particular attention has been paid to glucose metabolism after contraction, ATP depletion 
and insulin stimulation. Each of these requires translocation of GLUT4 to the cell 
membrane, and may require activation of glucose transporters by p38. In contrast, 
AICAR stimulates glucose transport without activation of p38, suggesting that p38 
activation may be an indirect consequence of accelerated glucose transport or 
metabolism. This study was designed to investigate the contribution of AMPK and p38 to 
ATP homeostasis and glucose metabolism to test the hypothesis that p38 reflects 
glycolytic activity rather than controls glucose uptake. Treating mature myotubes with 
rotenone caused transient ATP depletion in 15 min with recovery by 120 min, associated 
with increased lactate production. Both ACC and p38 were rapidly phosphorylated, but 
ACC remained phosphorylated while p38 phosphorylation declined as ATP recovered. 
AMPK inhibition blocked ATP recovery, lactate production, and phosphorylation of p38 
and ACC. Inhibition of p38 had little effect. AICAR-induced ACC phosphorylation, but 
not lactate production or p38 phosphorylation. Finally, removing extracellular glucose 
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potentiated rotenone-induced AMPK activation, but reduced lactate generation, ATP 
recovery and p38 activation. Thus, glucose metabolism is highly sensitive to ATP 
homeostasis via AMPK activity, but p38 activity is dispensable. Although p38 is strongly 
phosphorylated during ATP depletion, this appears to be an indirect consequence of 
accelerated glycolysis. 
2.2 Introduction 
 Skeletal muscle has an exceptional capacity to alter its glucose metabolism in 
response to changes in energy demand and glucose availability. For example, glucose 
uptake can increase by 3-10-fold during contraction and insulin stimulation.  Insulin-
mediated glucose uptake is an important part of whole body glucose homeostasis, but can 
be disrupted, leading to type II diabetes. Insulin resistance does not affect glucose uptake 
stimulated by contraction or ATP depletion (Musi et al., 2001). These stimuli accelerate 
the metabolism of glucose by product depletion rather than substrate accumulation, and 
suggest a strategy to compensate for insulin resistance. 
 Elevated glucose uptake depends strongly on the translocation of glucose 
transporter protein 4 (GLUT4) to the cell membrane, but is also influenced by the 
subsequent disposal of glucose through glycolysis, glycogenesis, and the pentose 
phosphate pathway (PPP) (Richter and Hargreaves, 2013).  Glucose disposal is subject to 
hormonal, allosteric and mass action effects separate from the regulation of GLUT4 
activity, and stimuli that increase glucose uptake activate multiple signaling pathways 
linked to regulation of glycolysis and glycogenesis (Hunter et al., 2011). Among these, 
the p38 mitogen activated protein kinase (p38) has been suggested to participate in both 
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GLUT4 activation to control acute glucose transport (Furtado et al., 2002) and more 
complex processes dependent on stresses associated with hyperglycemia and disruption 
of metabolic homeostasis (Novellasdemunt et al., 2013; Susztak et al., 2006). This 
suggests two models describing the relationship between p38 and glucose transport.  
The first model proposes that concomitant activation of Akt or AMPK and p38 facilitates 
separate processes of GLUT4 translocation and transporter activation. This model is 
primarily derived from hypoxic or ischemic cardiac myocytes, insulin-stimulated cells, 
and cells not expressing GLUT4. Insulin directly activates both Akt and p38 (Furtado et 
al., 2002), while hypoxic conditions induce ATP depletion and AMPK activation, which 
subsequently activates p38 (Li et al., 2005; Pelletier et al., 2005). AMPK appears to 
recruit p38 to a transforming growth factor-beta-activated protein kinase 1-binding 
protein (TAB1) macromolecular complex, where it undergoes autophosphorylation (Li et 
al., 2005). In support of this,  inhibiting AMPK suppresses p38 activation and glucose 
uptake following mitochondrial poisoning (Pelletier et al., 2005). Likewise, p38 
inhibitors reduce insulin- and contraction-stimulated glucose uptake without changing the 
cell surface availability of GLUT4 (Somwar et al., 2001; Somwar et al., 2000). In heart 
muscle, p38 inhibitor SB203580 inhibits both 5-Aminoimidazole-4-carboxamide 
ribonucleotide (AICAR)- and hypoxia-stimulated glucose uptake (Pelletier et al., 2005). 
In cells expressing only glucose transporter protein 1 (GLUT1), inhibition of p38 blocks 
AICAR-stimulated glucose uptake, potentially by preventing p38-mediated activation of 
constitutively-resident GLUT1 transporters (Xi et al., 2001). In this model, energy 
depletion is signaled by an increase in AMP, which activates AMPK. AMPK then 
phosphorylates TBC1 domain family member 1 (TBC1D1) to initiate GLUT4 transport 
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(Kramer et al., 2006) and separately causes phosphorylation of p38 to activate glucose 
transporters. 
 The second model proposes that GLUT4 translocation is sufficient for maximal 
transport activity independent of p38 activity. This model is primarily derived from 
AICAR-stimulated skeletal myocytes and targeted genetic disruption of p38 isoforms. It 
is prompted by the recognition that the pyridinyl imidazole p38 inhibitors also reduce Akt 
phosphorylation and may directly interfere with glucose transport (Antonescu et al., 
2005; Lali et al., 2000). For example, transgenic expression of dominant-negative p38α/β 
isoforms has little effect on insulin-stimulated glucose uptake, but SB203580 still reduces 
glucose transport, even in p38-defective cells (Antonescu et al., 2005), and disruption of 
p38β expression fails to alter insulin-stimulated glucose uptake in either adipose or 
muscle (Turban et al., 2005). AICAR treatment significantly increases AMPK 
phosphorylation without p38 phosphorylation in L6 myoblasts, myotubes and isolated rat 
extensor digitorum longus (EDL), so AICAR-induced glucose uptake occurs without p38 
activation (Ho et al., 2007).   
Activation of p38 may be related to processes parallel to GLUT4 activation 
during periods of energy stress. ATP depletion induces glucose uptake and activation of 
glycolytic pathway. The capacity of pyruvate dehydrogenase (PDH) to metabolize 
pyruvate and mitochondrial shuttle to regenerate NAD
+
 may be saturated, resulting in 
accumulation of NADH (Locasale and Cantley, 2011). NAD
+
/NADH ratio has been 
shown to decrease by more than tenfold in the presence of mitochondrial inhibitors 
compared with control (Fendt et al., 2013). Furthermore, pre-treating cardiomyocytes 
with resveratrol, a NAD
+
 booster, caused a significant reduction in ischemia–reperfusion-
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induced p38 phosphorylation (Becatti et al., 2012). This suggests an alternative model in 
which energy depletion is signaled by elevated AMP, activating AMPK. AMPK then 
phosphorylates TBC1D4 to initiate GLUT4 translocation, which is necessary and 
sufficient for maximum glucose uptake (Kramer et al., 2006). Subsequent metabolism of 
glucose disrupts the redox balance within the glucose network, resulting in 
phosphorylation of p38. 
 Mitochondrial inhibition is a well-established experimental strategy to challenge 
the energy status of cells and to study how cells cope with such a challenge (Bashan et 
al., 1993). Rotenone inhibits the transfer of electrons from iron-sulfur centers in complex 
I to ubiquinone, disrupting the oxidation of nicotinamide adenine dinucleotide (NADH) 
and mitochondrial synthesis of ATP (He et al., 2013). Limited ATP production causes a 
rise in the AMP: ATP ratio and activates AMPK. This study is designed to investigate the 
role of AMPK and p38 in ATP homeostasis and glucose metabolism during 
mitochondrial inhibition and to test the hypothesis that activation of p38 following ATP 
depletion depends on glycolysis. Our results show that ATP homeostasis is highly 
sensitive to AMPK activity, but that p38 activity is dispensable. Reducing AMPK activity 
blocks p38 activation, and this AMPK-induced increase p38 phosphorylation is 
dependent on extracellular glucose, but not on actual glucose uptake. These results are 
partially consistent with p38 being indirectly activated by glycolytic flux under energy 




2.3 Materials and Methods 
2.3.1 Materials 
 Antibodies for p38 T180/Y182, ACCS79 and Akt S473 were purchased from Cell 
Signaling Technology. C2C12 cells were obtained from the American Type Culture 
Collection (ATCC, Manassas, VA). Dublecco's Modified Eagle's Medium (DMEM) was 
purchased as a powdered mixture (Corning 50-003), supplemented with 3.7g/L NaHCO3 
, and sterilized by 0.2 um filtration. Rotenone (Rot, 1 mM), FCCP (4 mM), dorsomorphin 
(Dors, 10 mM, also known as Compound C), cytochalasin B (20mM) and SB203580 (10 
mM) were prepared as concentrates in DMSO and diluted to working strength in serum 
free DMEM prior to application to cells. AICAR was directly dissolved in serum free 
DMEM to give a final concentration of 0.1-10 mM.  
2.3.2 Cell Culture 
 C2C12 myoblasts were maintained in growth medium (GM, DMEM 
supplemented with 10 % fetal bovine serum (FBS, Hyclone), 100 IU/ml penicillin, and 
100 μg/ml streptomycin) in a humidified incubator under 10 % CO2 at 37 °C. Cells were 
seeded at 4.4x103 cells/cm2 on 12-well plates, and allowed to proliferate 1-2 days to 60-
80% confluence, at which point they were switched to differentiation media (DM, 
DMEM supplemented with 2% horse serum (Hyclone) and antibiotics). Media was 
replenished every 48 h. Interventions were performed after 4-5 days in DM, with 44±7% 
of culture area covered by myotubes.  
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 Mature myotubes were depleted of ATP by exposure to rotenone. Cultures were 
rinsed twice with serum and antibiotic free DMEM (SFM) and incubated 60min prior to 
application of rotenone.  In most experiments, all wells were exposed to rotenone for 15 
or 60 minutes, as indicated. For time-course studies, individual wells were exposed to 
drug for different times, but to minimize manipulation of each plate, the total pre-
incubation and incubation time was 3 hours for all treatment groups.  All cells were 
switched to SFM concurrently, treated with 250 nM rotenone or DMSO for the indicated 
time periods, and harvested concurrently. This resulted in varying length incubations in 
SFM equal to the difference between three hours and the duration of rotenone exposure. 
ATP recovery mechanisms were investigated by combining rotenone treatment with other  
treatments. Inhibitors of AMPK (dorsomorphin), glucose transporters (cytochalasin B) or 
p38 (SB203580) were included in both the pre-incubation media and the treatment media. 
Glucose restriction media was prepared from glucose, glutamine and pyruvate free 
DMEM (Corning 90-113), supplemented with 4mM glutamine, 0.5 mM glucose, and 
24.5 mM mannitol. . 
 Culture media was collected immediately after treatment and boiled for 5 min to 
inactivate enzymatic activity. Samples were cleared by centrifugation at 16k xg for 2 min 
and stored at -20°C. Cultures were rinsed with ice cold PBS twice, and collected by 
scraping in detergent buffer (1% Triton-X100, 50 mM tris, 300 mM NaCl, 5 mM EDTA) 
supplemented with protease inhibitors (Sigma), 100 mM NaF, and 4 μg/ml NaVO3. 
Because early experiments revealed that even a few minutes delay could substantially 
reduce ATP content, an aliquot of this suspension was immediately diluted 10x in water 
and heated for 2 min at 98°C to inactivate nucleotidases. The rest of the sample was 
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incubated on ice for 30 min. Insoluble material from both samples was cleared by 
centrifugation at 16k xg for 5 min.  Soluble protein concentration was assayed by 
bicinchronic acid assay (Pierce).   
2.3.3 Cell morphology 
 Micrographs of cultures were obtained immediately after treatment under phase 
contrast illumination using 20x objective (Leica). Two random fields were captured for 
each well, covering 13.5 mm2. Culture confluence and area density of myotubes were 
determined by point counting.  
2.3.4 Metabolite assays 
 Cytoplasmic ATP was determined by the firefly luciferase method (33). ATP 
standards and samples were distributed in duplicate to 96 well plates, and assay buffer 
(1.5 mM MgCl2, 0.15 mM EDTA, 18 μM dithiothreitol (DTT), 0.25 mg/ml bovine serum 
albumin (BSA), and 6 mM HEPES, pH 7.8.) containing 30 µM luciferin and 0.75 µg/ml 
luciferase was rapidly added using a multi-channel pipettor. Luminescence was measured 
within 5 minutes (FLx800, BioTek). Luminescence values were calibrated to a standard 
curve and normalized to lysate protein content.  
 Lactate was measured by the lactate dehydrogenase method (Pesce et al., 1975).  
Samples were reacted in assay buffer (1 M glycine, 200 mM hydrazine, 2 mM NAD+, 
pH=9.5) containing 20 U/ml LDH at room temperature for 30 min. Absorbance at 340 
nm was measured, and lactate concentration was calculated using 6.22 as the millimolar 
extinction coefficient for NADH. Values were normalized to lysate protein content. 
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2.3.5 Western-blot analysis 
 To assay phosphorylation of p38, Akt and ACC, 4 μg soluble protein was 
separated by SDS-PAGE through 10 % (p38 and Akt) or 7 %(ACC) acrylamide gels. 
Protein was transferred to nitrocellulose membranes, blocked with 5% nonfat dry milk in 
Tween-TBS (TTBS) and hybridized with phospho-specific antibody to p38 T180/Y182 
(1:2000),  Akt S473(1:2000) or ACC S79 (1:2000). Membranes were rinsed and 
incubated with horseradish peroxidase conjugated secondary antibody (Jackson, 
1:80,000). Bands were detected by enhanced chemiluminescence (Amersham), visualized 
by exposure to radiographic film, and quantified by scanning densitometry. All samples 
from an experiment were run on the same gel, and normalized to the average of that 
experiment’s DMSO-control samples.   
2.3.6 Statistical analysis 
 Unless otherwise noted, experiments were repeated as three independent 
procedures, with duplicate or triplicate wells averaged prior to statistical analysis, giving 
a sample size of n=3 per group. This provides statistical resolution of 4 standard 
deviations with 91% power or two standard deviations with 25% power. Results are 
reported as means with S.D. to indicate population variability unless otherwise noted. 
The IC50 and EC50 were determined by fitting experimental data to the Hill equation 
using MatLab software version 2014a (fitnlm, MathWorks, Inc.), and are reported as 
mean ± S.E. to indicate confidence in the estimates. Time course data were fit to an 
exponential function for determination of time constant. Rotenone- dorsomorhpin and 
rotenone-glucose experiments were analyzed by two-way ANOVA. Dose and time 
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experiments were analyzed by 1-way ANOVA followed by post hoc T-tests using 
Bonferroni correction for multiple comparisons. 
2.4 Results 
 Rotenone decreases ATP and increases phosphorylation of ACC and p38 with 
similar dose dependence (Fig. 2-1). Because rotenone can induce oxidative stress at high 
doses (Li et al., 2003), we first determined the minimum concentration to induce 
metabolic stress. Rotenone induced a dose-dependent reduction in ATP after 15 minutes 
(Fig. 2-1a), with IC50 of 40±20 nM (mean±s.e.m) and maximal depletion of 58±5% 
above 250nM. This was associated with a dose-dependent phosphorylation of p38 with 
EC50 17±5 nM (Fig. 2-1b) and phosphorylation of ACC with EC50 12±9 nM (Fig. 2-1c). 
The EC50 for neither p38 (p=0.15) nor ACC (p=0.24) was significantly different from 






Figure 2-1 Effect of rotenone on ATP content and kinase activity 
Effect of 15 minutes rotenone on a) cellular ATP content and the phosphorylation of b) p38 and c) ACC. 
Representative blots shown for p38 and ACC. All values are expressed relative to control. n=3 experiments 
with duplicate wells. 
 
 
 Rotenone poisoned myotubes recover ATP content within 2 hours, coincident 
with loss of p38 phosphorylation, but not ACC (Fig. 2-2). Compensation for 
mitochondrial poisoning was associated with an increase in lactate production rate from 
19.0±4.7 µmole/g protein/min to 42.1±9.2 µmole/g/min  (p<0.0001). Although lactate 
production appeared to increase further during recovery, this could not be statistically 
resolved (p=0.12; Fig. 2-2b). Likewise, phosphorylation of ACC, indicative of AMPK 
activity, increased to 6.4±1.2 fold of control by 15 minutes and remained elevated for the 
duration. ATP recovered from 63±11% of control at 15 minutes to 84±9.5% at 120 min 
(p=0.0023 Fig. 2-2a). The recovery of ATP was associated with a decline in 
phosphorylation of p38 from 3.6±0.5 fold to 0.9±0.5 fold (p=0.02; Fig. 2-2c) but not 
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while the half-time of p38 dephosphorylation was 81±38 min, and these values could not 








Figure 2-2 The time course of ATP content and kinase activity 
The time course of a) ATP content b) rate of lactate release and phosphorylation of c) p38 and d) ACC 
during exposure to rotenone in the presence of complete media. Representative blots shown for p38 and 




 Rotenone does not alter myotube density or morphology during our experimental 
window (Fig. 2-3). Although prolonged incubation with high doses of rotenone can 
induce apoptosis or necrosis, two hours with 250 nM rotenone did not reduce myotube 
number (Fig. 2-3c) nor induce visible changes in morphology, indicating little gross 







Figure 2-3 Morphology of C2C12 myotubes 
Rotenone has no effect on myotube number. a) Pre-treatment b) DMSO and d) 250 nM rotenone (Scale bar 
0.25mm). Quantification of myotube density (c) White bars, pre-treatment; Gray bars, DMSO; Black bars, 




 Inhibition of AMPK with Dors (Compound C) prevents ATP recovery and p38 
phosphorylation (Fig. 2-4). Dors is reported to inhibit AMPK activity at concentrations 
between 10-50 μM (17), and incubation with 40 μM reduced ACC phosphorylation at 60 
minutes from 3.4±0.7 fold with rotenone alone to 1.7±0.2 fold  (p=0.01; Fig. 2-4d). Dors 
alone induced only a small and not-significant reduction. At 15 minutes, Dors failed to 
produce a significant effect on ACC phosphorylation (data not shown), which may 
indicate that the Dors dose chosen is only marginally capable of countering AMPK 
activity. In the absence of Dors, ATP recovered from 27±4.1 μmole/g at 15 min to 35±0.1 
μmole/g at 60 min (Fig. 2-4a), a gain of 7.6±1.1 μmole/g. In the presence of Dors, the 
initial ATP decline was greater (16±3.8 μmole/g), and recovered only to 18±5.5 μmole/g 
(Fig. 2-4a), representing recovery of only 1.1±0.4 μmole/g, significantly less than without 
Dors (p=.0004). Likewise, lactate production rate was reduced by Dors from 37±2.0 
μmole/g/min to 26±3.1 μmole/g/min (rotenone X Dors p=0.0012, Fig. 2-4b). Rotenone-
induced p38 phosphorylation at 15 min was reduced by Dors from 5.7±1.7 fold of control 
to 1.6±0.9 fold (p=0.02, Fig. 2-4c). There was a tendency for Dors alone to increase p38 





Figure 2-4 The effect of Dors on rotenone poisoning  
The effect of Dors on rotenone-induced metabolite and kinase activity at recovery (60 min: a, b, d) and 
maximal ATP depletion (15 minutes: c). ATP content (a) and lactate production rate (b) in myotube 
cultures treated with rotenone with or without Dors. Phosphorylation of c) p38 at 15 minutes and d) ACC 
phosphorylation at 60min. Western blots are representative of 3 independent experiments, and bars 
represent Mean ± SD. 
‡ 
interaction between rotenone and Dors p < 0.05; 
* 
main effect of rotenone p < 0.05; 
#








 Direct activation of AMPK with AICAR does not change lactate production or 
p38 phosphorylation (Fig. 2-5). Because conflicting reports of the role of AMPK in p38 
activation may be linked to energy depletion (Ho et al., 2007; Li et al., 2005), we 
examined the activation of p38 by the AMP-mimetic AICAR in the absence of ATP 
depletion. AICAR increased ACC phosphorylation, to a maximum of 6-fold with IC50 of 
0.18±0.08μM (Fig. 2-5a.). However, AICAR did not increase p38 activation or lactate 
production (Fig. 2-5b & c), even at substantially higher concentrations, confirming that, 
although AMPK facilitates activation of p38 following rotenone treatment, AMPK itself 
is insufficient to activate p38 directly.  
 
 
Figure 2-5 Effect of AICAR on phosphorylation of ACC and p38 
Effect of AICAR on phosphorylation of ACC (a) and p38 (b) and lactate release (c). Representative 
Western blots also show concurrent treatment with 250 nM rotenone as positive control. Mean ± SD from 3 
experiments; 
*






 Inhibition of p38α and p38β with SB203580 altered ATP recovery only at doses 
much higher than required to block kinase phosphorylation (Fig. 2-6). The pyridinyl 
imidazole SB203580 has been reported to inhibit p38α/β with IC50 0.3-0.5 μM, but is 
often applied at 10 μM, and may have off-target effects at concentrations above 3 μM 
(Lali et al., 2000).  Rotenone-induced p38 phosphorylation at 15min was reduced from 
3.7±0.5 fold of control to 2.2±0.3 in the presence of as little as 1 μM SB203580, and 
1.3±0.7 fold with 20 μM SB203580 (p=0.0029, Fig. 2-6c). The dose range tested did not 
allow accurate determination of IC50, which appears to be less than 1 μM. ATP recovery 
was inhibited by SB203580, but only at doses of 10 μM and greater (Fig. 2-6a, 
p=0.0006). A slight reduction in lactate production rate was also noted only at the highest 
dose of 20 μM (p= 0.0009 Fig. 2-6b). SB203580 has been reported to directly inhibit Akt 
phosphorylation (16, 20). Rotenone alone reduced Akt S473 phosphorylation to 0.62±0.2 
(p=0.001), and SB203580 resulted in a further reduction to 0.38±0.14 at 1 μM and 
0.08±0.02 at 20 μM (Fig. 2-6d). Incubation with 1μM SB203580 and 0.1μM BIRB796 
further decreased p38 phosphorylation, but had no effect on ATP recovery, similar to 
SB203580 treatment (Fig 2-6e, f). Inhibitor doses lactate production, indicating that p38 





Figure 2-6 The influence of SB203580+ Birb on rotenone poisoning 
The influence of SB203580 alone (a-d) or with Birb796 (e-f) on rotenone-induced metabolite and kinase 
activity at recovery (60 min) and maximal ATP depletion (15 min). ATP content (a: 60 minutes; e: 15 
minutes) Lactate production rate (b, 60 minutes) p38 phosphorylation (c; f 15 minutes) and Akt 
phosphorylation (d, 15 minutes). (Mean ± SD; 
†
 significantly different from control, p < 0.0033; 
††
 
significantly different from rotenone alone, p < 0.0033. *main effect of rotenone p < 0.05; # main effect of 
SB203580+Birb796 p < 0.05; 




 Inhibition of glucose uptake with cytochalasin B reduced lactate production 
without altering p38 phosphorylation. (Fig. 2-7). Because AMPK activity was required 
for both increased lactate production and p38 phosphorylation, but p38 activity was 
dispensable for ATP recovery, we tested whether the AMPK-facilitated lactate 
production was necessary for p38 phosphorylation. Incubation with 1μM cytochalasin B 
blocked the rotenone-induced increase in lactate production and exaggerated the decline 
in cytoplasmic ATP (Fig. 2-7a,b), which is consistent with inhibition of glucose transport. 
Cytochalasin B alone had no effect on ACC and p38 phosphorylation. In the presence of 
rotenone, there was a tendency for cytochalasin B to decrease p38 (p=0.29) and increase 
ACC phosphorylation (p=0.12), but these effects could not be statistically resolved (Fig. 
2-7c, d). This suggests that uptake of extracellular glucose is not necessary for induction 
of p38 activity following ATP depletion, but that AMPK contributes to p38 





Figure 2-7 The effect of cytochalasin B on the rotenone poisoning 
Effect of glucose transporter inhibition on the rapid response of myotubes to rotenone poisoning.(a) ATP 
content, (b) lactate production rate, (c) p38 phosphorylation, and (d) ACC phosphorylation with 250 nM 
rotenone at 15min. Western blots are representative of 3 independent experiments, and bars represent Mean 
± SD. 
‡ 
interaction between rotenone and cytochalasin B p < 0.05; 
* 
main effect of rotenone p < 0.05; 
#
 main 






 Restricting extracellular glucose during the recovery phase eliminated lactate 
production and reduced p38 phosphorylation (Fig. 2-8). Because cytochalasin B disrupts 
actin filaments, including those of nascent sarcomeres (Manasek et al., 1972), and the 
cytochalasin B results were inconclusive, we further tested the involvement of glucose in 
roteneone-induced p38 phosphorylation by restricting extracellular glucose. In the 
absence of rotenone, restricting glucose to 0.5 mM reduced lactate production to 8.9±0.5 
μmole/g/min, with a modest and unresolvable increase in ATP (Fig. 2-8a), suggesting 
that cells are easily able to accommodate this challenge by increasing oxidation of 
glucose. Combined with rotenone, glucose restriction resulted in a significant 
exaggeration of ATP depletion (Fig. 2-8a). Rotenone-treated cells in low glucose media 
were able to increase lactate production from 8.9±0.5 umole/g/min to 13.5±0.6 
µmole/g/min (p=0.0002), but did not rise to control-25 mM glucose levels (Fig. 2-8b). 
Rotenone-induced ACC phosphorylation increased from 3.2±0.4 fold of control in 25 
mM glucose media to 4.7±1.0 fold of control in 0.5 mM glucose with mannitol media 
(p=0.0072)  (Fig. 2-8d.), consistent with the exaggerated decline in ATP. In contrast, 
glucose restriction reduced p38 phosphorylation from 4.2±0.6 fold to 2.7±0.3 fold of 
control (p=0.0008) (Fig. 2-8c). Because osmotic pressure can influence both glucose 
transport and p38 phosphorylation, these experiments were also performed in media 
containing 0.5 mM glucose without osmotic balance by mannitol. This reduction in 
extracellular osmotic pressure had no further effect on ATP depletion, lactate production, 




Figure 2-8 Effect of glucose restriction on rotenone poisoning 
Effect of glucose restriction on the rapid response of myotubes to rotenone poisoning.(a) ATP content, (b) 
lactate production rate, (c) p38 phosphorylation, and (d) ACC phosphorylation with 250 nM rotenone at 
15min.  Western blots are representative of 3 independent experiments, and bars represent Mean ± SD. 
‡ 
interaction between rotenone and glucose p < 0.05; 
* 
main effect of rotenone p < 0.05; 
#
 main effect of 







 Inhibiting mitochondrial respiration in myotubes with rotenone rapidly depletes 
cellular ATP with substantial recovery by two hours. Both ACC and p38 are rapidly 
phosphorylated, and the synchronous recovery of ATP and decline in p38 
phosphorylation suggests that p38 may participate in a feedback control process. 
However, preventing glycolytic recovery by dorsomorphin or glucose restriction 
abolishes p38 activation, while inhibition of p38 with SB203580 or Birb 796 has no 
effect on ATP recovery or AMPK activity. We interpret these results as indication that 
phosphorylation of p38 in rotenone-stimulated muscle cells requires AMPK and 
extracellular glucose, but does not participate in control of glycolysis. 
 These observations are generally consistent with literature reports. Mitochondrial 
poisoning by DNP evokes a similar time-course of ATP depletion and recovery (Bashan 
et al., 1993).  Reports of cytoplasmic ATP in cultured myotubes span a surprisingly wide 
range from 5-50 μmoles ATP per gram of protein (Bashan et al., 1993; Dehne et al., 
2007; Wagenknecht and Lieberman, 1991). Some of this difference can be attributed to 
normalization by Triton-soluble, SDS-soluble, or other measures of protein. We found 
ATP content to be extremely labile, decaying at 4 μmole/g protein/hour, even at 4 °C 
(data not shown). Because of this, collection and nucleotidase inactivation of ATP 
samples was performed as rapidly as possible, generally less than 10 minutes between 
application of lysis buffer and boiling.  GLUT4 translocation following insulin or 
mitochondrial poisoning is reported to complete within 5 minutes (Michelle Furtado et 
al., 2003), well before our first time point, so the relatively constant rate of lactate 
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production is reasonable. Finally, under similar conditions, reports of ACC 
phosphorylation and p38 phosphorylation are between 3 and 10 fold of control (Hao et 
al., 2010; Newhouse et al., 2004; Pelletier et al., 2005).  Variability in ACC 
phosphorylation was somewhat high, reflecting the very low level of phosphorylation in 
vehicle-treated cultures and the limited dynamic range of film-based quantification. 
 AMPK is generally accepted to stimulate GLUT4 translocation, to inhibit energy 
consuming processes like lipogenesis, and to facilitate energy producing processes like 
glycolysis (Hardie and Ashford, 2014). In the present study, inhibition of AMPK 
effectively blocks lactate production and ATP recovery following rotenone treatment. 
Although Dors can also inhibit a number of receptor-mediated kinases (Bain et al., 2007; 
Boergermann et al., 2010; Yu et al., 2008), these pathways are unlikely to contribute to 
the acute response of isolated myotubes. With AMPK inhibited, metabolic compensation 
would be limited to a combination of substrate effects and allosteric action, which may be 
capable of doubling the rate of ATP synthesis (Ghorbaniaghdam et al., 2014), and the 
present results support that prediction. C2C12 myotubes have relatively low expression 
of GLUT4, but these results suggest that about half of the increase in glycolysis can be 
attributed to substrate effects and half to AMPK-dependent effects, including GLUT4 
translocation and phosphofructokinase 2 (PFK2) activation. Inhibition of AMPK also 
blocked p38 phosphorylation, and AMPK has been reported to participate in activation of 
p38 through formation of a TAB1 complex (Li et al., 2005).  Activation of AMPK 
appears not to be sufficient to nucleate this process, as AICAR treatment fails to induce 
p38 activation (Fig 2-5b) (Ho et al., 2007). Treatments where AMPK-TAB1 mediated 
activation of p38 is reported seem to include oxidative stress (Lanna et al., 2014; Li et al., 
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2005), and this complex may help to refine the cellular response to excess AMP based on 
additional chemical states.  
 The p38 MAP kinase has been suggested to activate glucose transporters to 
facilitate glucose uptake (Somwar et al., 2000). Subsequent work from the same group 
seems to refute that role (Antonescu et al., 2005), and the present results (Fig.2-6) also 
support no role for p38 in glucose uptake. Although SB203580 and other pyridinyl 
imidazole compounds are frequently described as specific inhibitors of p38α and p38β, 
this specificity depends strongly on careful control of concentration. The present results 
indicate near maximal reduction of p38 phosphorylation with only 1μm SB203580, 
which has no effect on lactate production or glycolytic recovery of ATP. There is 
progressive reduction in lactate production and ATP recovery above 10 μM, which 
closely parallels reduction in Akt phosphorylation, and high concentrations of SB203580 
compounds have been reported to inhibit Akt (Lali et al., 2000). Although SB203580 
does not block p38γ, which is the major isoform in mature skeletal muscle, adding 
BIRB796, which is highly selective for p38 γ (Kuma et al., 2005) in combination with 
SB203580 further decreased p38 phosphorylation but had no effect on ATP recovery 
(Fig. 2-6e, f). 
 Although these experiments do not support a requirement for p38 in the 
acceleration of glycolysis, there are limitations in the experimental design that might 
obscure this effect. According to model 1, p38 acts by facilitating glucose uptake by 
activation of GLUT4 transporters, and glucose uptake was not directly measured. C2C12 
myotubes express relatively little GLUT4 (Kotliar & Pilch, 1992), relying more on 
GLUT1 for glucose uptake. It is GLUT1 transporters in Clone 9 cells that seem to be 
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regulated by p38 (Xi et al., 2001), which suggests C2C12 myotubes might even be more 
sensitive to p38 than other muscle models. Our cells were maintained and treated in 
media containing superphysiological 25 mM glucose, which may provide enough driving 
force for transport to overcome permeability limitations in the baseline conditions. 
Pharmacological interventions were chosen in this study to minimize long-term 
compensatory processes associated with genetic manipulations. 
 The objective of this study was to determine whether p38 regulates glycolytic 
activity or is activated as a consequence of glycolysis. Results indicate that it does not 
control glycolysis, but the converse is less clear. Phosphorylation of p38 does require 
AMPK activity, but the interventions used to reduce glucose metabolism had mixed 
outcomes. Cytochalasin B disrupts actin filaments, upon which many cellular transport, 
motility, and adhesion processes depend, and prevents the increase in lactate production 
without blocking lactate production completely, but has no effect on p38. Glucose 
restriction, by simple mass action, also prevents the increase in lactate production, 
reduces basal lactate production, exaggerates the ATP-stress associated with rotenone 
even beyond cytochalasin B, and does reduce p38 phosphorylation. One way to reconcile 
these data is the possibility that p38 phosphorylation depends on extracellular glucose 
and allows the cell to select among extracellular nutrients for ATP recovery. There are 
glucose sensitive receptors and channels, but they do not seem particularly prominent in 
skeletal muscle (Diez-Sampedro et al., 2003; Ozcan et al., 1998). It is possible that the 
combination of rotenone and cytochalasin B activate p38 through a different mechanism 
than rotenone alone. That is, that cytochalasin B may effectively block glucose transport 
and glycolysis-induced p38 activation, but render the cell more sensitive to volume, 
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osmotic, or oxidative stresses. It seems likely that activation of p38 following rotenone 





Modulation of glucose metabolism and AMPK activity through 
redox state and ROS in C2C12 myotubes 
   
3.1 Abstract 
 From rest to exercise, the rate of glucose metabolism dramatically increases with 
ATP turnover. This increase is accompanied and mediated by changes in intermediate 
metabolite concentration. Muscle contraction causes a small drop of ATP and a 
significant increase in AMP. AMP/ATP ratio strongly influences the activity of 
glycoylsis enzymes. NAD
+
/NADH ratio strongly influences the disposal of pyruvate by 
the oxidative or reductive pathways. The goal of this study was to evaluate the 
contribution of cellular redox state in the balance of oxidative and anaerobic metabolism 
to test the hypothesis that NADH oxidation and ATP depletion increase glucose oxidation 
via both mass action and PDH phosphorylation. Treating C2C12 myotubes with PMS 
completely oxidized NADH at 200μM, but oxygen consumption, ATP depletion, DCFH2 
oxidation and the phosphorylation of PDH were significantly induced by PMS only 
above 1μM. Thus, NADH oxidation is not sufficient to influence glucose oxidation, but 






 The rate of glucose metabolism changes dramatically with activity. The control of 
that rate is mediated by several glucose metabolites, such as ADP, AMP, and NADH 
(Sahlin et al., 1987). Skeletal muscle catabolizes glucose to generate ATP via glycolysis 
and oxidative phosphorylation. Glycolytic flux is facilitated by glucose uptake and the 
regulation of several key enzymes along the glycolysis pathway. Phosphofructokinase 
(PFK) controls the conversion of fructose 6-phosphate into fructose 1,6-biphosphate and 
has been suggested to be a critical step in determining the rate of glycolysis during 
muscle contraction (Schmitz et al., 2013). In order to adapt to dramatic changes of 
condition, such as resting and sprinting, skeletal muscle has ability to reprogram glucose 
metabolism. During periods of low activity, muscular ATP demand is satisfied primarily 
by oxidative metabolism of fatty acids. As activity increases, much of the marginal 
energy derives from oxidative metabolism of glucose. As activity increases further, 
anaerobic metabolism of glucose into lactate increases dramatically.  
 Regulation and control of the scaling of ATP synthesis involves a large network 
of metabolites and metabolic sensors. The fluxes of glucose through glycolysis and 
mitochondrial respiration are regulated by mass action, allosteric regulation through 
ATP/AMP. During rest, the ratio of ATP/AMP is high. During exercise, the accumulation 
of AMP activates the energy sensor, 5' AMP-activated protein kinase (AMPK). Lowering 
the ratio of ATP/AMP increases PFK and PDH activity via allosteric regulation (Hardie 
and Ashford, 2014). 
 Muscle cells also possess several metabolic sensors which are regulated by the 
NAD
+
/NADH ratio. Pyruvate stands at a metabolic crossroad between anaerobic and 
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aerobic metabolism. The ability of muscle cells to switch between lactate production and 
pyruvate oxidation may be determined by the ratio of NAD
+
/NADH. Pyruvate 
dehydrogenase complex (PDH) catalyzes irreversible decarboxylation of pyruvate into 
acetyl-CoA (Sugden and Holness, 2006). The activity of PDH is highly regulated by 
pyruvate dehydrogenase kinases (PDKs) (Sugden and Holness, 2006). During high 
intensity exercise, the accumulation of NADH allosterically stimulates PDK activity 
which exerts an inhibitory effect on PDH through the phosphorylation of the E1-α 
subunit (Bowker-Kinley et al., 1998; Rardin et al., 2009). Lactate dehydrogenase (LDH) 
is a key enzyme in anaerobic metabolism converting pyruvate and NADH into lactate and 
NAD
+
. LDH converting pyruvate to lactate is considered to be near equilibrium 
(Williamson et al., 1967). Accumulation of NADH and pyruvate increase lactate 
production by mass action.  
 Redox state and the accumulation of ADP or AMP may serve as molecular 
transducers driving a switch from oxidative phosphorylation to glycolysis. The goal of 
this study was to evaluate the contribution of cellular redox state in the balance of 
oxidative and anaerobic metabolism. We used phenazine methosulfate (PMS) to 
chemically alter cellular redox state to test the hypothesis that the oxidation of NADH to 
NAD
+
 increases oxidative metabolism by both mass action and activation of PDK. We 
found that low dose PMS increases NAD
+
/NADH ratio without any change on PDH 
phosphorylation or oxidative metabolism. PMS-induced oxygen consumption was 
correlated with ROS production, ATP depletion and ACC phosphorylation suggesting 
that ROS-AMPK signaling may contribute to the glucose oxidation.  
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3.3 Materials and Methods 
3.3.1 Materials 
 Antibodies for ACC
S79
, and PDHE1-A type I 
S293
 were purchased from Cell 
Signaling Technology and EMD Millipore, respectively. CM-H2DCFDA was purchased 
from Invitrogen and was dissolved in DMSO to 10mM on the same day of experiment. 
C2C12 cells were obtained from the American Type Culture Collection (ATCC, 
Manassas, VA). Dulbecco’s modified Eagle’s medium (DMEM) was purchased as a 
powdered mixture (Corning 50–003), supplemented with 3.7 g/L NaHCO3, and sterilized 
by 0.2 um filtration. PMS (10mM) was prepared in dH2O as stock solution. FCCP 
(5mM), rotenone (10mM), antimycin a (10mM) were prepared in DMSO.  
3.3.2 Cell culture 
 C2C12 myoblasts were maintained in growth medium (GM, DMEM 
supplemented with 10% fetal bovine serum (FBS, Hyclone), 100IU/ml penicillin, and 
100 μg/ml streptomycin) in a humidified incubator under 10% CO2 at 37 °C. Cells were 
seeded at 1.6x10
4
 cells/well , 2x10
3
 cells/well, and 1.6x10
3
 cells/well on 12-well plates, 
XFp 8-well plates and 96-well plates, respectively and allowed to proliferate 1-2 days to 
60-80% confluence, at which point they were switched to differentiation media (DM, 
DMEM supplemented with 2% horse serum (Hyclone) and antibiotics). Media was 
replenished every 48 h. Interventions were performed after 5-6 days in DM. 
 Mature myotubes were rinsed twice with serum and antibiotic-free DMEM (SFM) 
and incubated 60 min prior to application of PMS. Culture were rinsed with ice-cold PBS 
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twice. Cultures collected for metabolite analysis were harvested by scraping in cold 
carbonate buffer (100mM Na2CO3, 20 mM NaHCO3, 20 mM NAM). Cultures collected 
for ACC phosphorylation and PDH phosphorylation were collected by scraping in 
detergent buffer (1%Triton-X100, 50mMtris, 300mM NaCl, 5mM EDTA) supplemented 
with protease inhibitors (Sigma), 100mM NaF, and 4ug/ml NaVO3. Sample was 
incubated on ice for 30min. Insoluble material from both samples was cleared by 
centrifugation at 16K xg for 5min. Soluble protein concentration was assayed by 
bicinchronic acid assay (Pierce). 
3.3.3 Metabolite assay 
 Lysate NAD and NADH contents were determined by alcohol dehydrogenase 
(ADH)-diaphorase enzymatic cycling using 40μl of sample and 200μl assay buffer 
(40μg/mL yeast ADH (Alfa Aesar, MA), 0.2% ethyl alcohol, 2mM MgCl2, 0.2 U/ mL 
diaphorase (Innovative Research, MI), 1μM resazurin (Alfa Aesar, MA)). Resorufin 
formation was monitored with excitation at 540 nm and emission at 590 nm every 2 
minutes for a total of 20 minutes. The standard curve is produced by measuring the rate 
of fluorescence increase by standards of known concentration of NAD
+
. NAD and 
NADH content are normalized to lysate protein content. For measurement of NAD, 10μl 
samples were diluted in 90μl lysis buffer and were incubated on ice, For measurement of 
NADH, 100μl samples were incubated for 15min at 60°C to destroy NAD
+
 (Wagner and 
Scott, 1994).  NAD
+
 was determined by subtracting NADH from NAD. 
 Cytoplasmic ATP was determined by the firefly luciferase method (Hsu and 
Burkholder, 2015). ATP standards and samples were distributed in duplicate to 96 well 
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plates, and assay buffer (1.5mM MgCl2, 0.15mM EDTA, 18μM dithiothreitol (DTT), 
0.25 mg/ml bovine serum albumin (BSA), and 6mM HEPES, pH 7.8) containing 30μM 
luciferin and 0.75 μg/ml luciferase was rapidly added using a multichannel pipettor. 
Luminescence was measured within 5min (FLx800, BioTek). Luminescence values were 
calibrated to a standard curve and normalized to lysate protein content. 
3.3.4 Western blot 
 To assay phosphorylation of ACC and PDH, 4 μg soluble protein was separated 
by SDS-PAGE through 7 % (ACC) or 10% (PDH) acrylamide gels. Protein was 
transferred to nitrocellulose membranes, blocked with 5% nonfat dry milk in Tween-TBS 
(TTBS) and hybridized with phospho-specific antibody to ACC
S79
 (1:2000) or PDHE1-A 
type I
S293
 (1:1000). Membranes were rinsed and incubated with horseradish peroxidase 
conjugated secondary antibody (Jackson, 1:80,000). Bands were detected by enhanced 
chemiluminescence (Amersham), visualized by exposure to radiographic film, and 
quantified by scanning densitometry. All samples from an experiment were run on the 
same gel, and normalized to the average of that experiment’s control samples.  
3.3.5 Metabolic flux analysis 
On the day of metabolic flux analysis, cells were changed to unbuffered DMEM 
(DMEM base medium (Seahorse Bioscience) supplemented with 25mM glucose, 1mM 
sodium pyruvate, 4mM glutamine, pH 7.4). Oxygen consumption rate (OCR) and 
extracellular acidification rate (ECAR) were determined in three measurement intervals 
(one measurement interval consists of a 3min mixing, 0min waiting ,and 3min 
measurement step) in live cells before and after sequential injection of PMS (final 
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concentration 0.01, 0.05, 0.1, 0.5, 1μM ) , FCCP (final concentration 1μM) to uncouple 
respiration and rotenone and antimycin a (final concentration rot 0.5μM/aa 0.5μM) to 
inhibit Complex I/III. Protein concentration of each sample was determined by 
bicinchronic acid assay (Pierce) and was used to normalize OCR and ECAR. 
3.3.6 Cellular ROS analysis 
 Mature myotubes were rinsed once and incubated 30 min with SFM. Cells were 
incubated with 10μM CM-H2DCFDA in SFM for another 30min in the dark prior to the 
treatment. Cultures were rinsed twice with DMEM (no NaHCO3) and exposed to PMS (0, 
0.05, 0.2, 1 μM) for 30min. Fluorescence was monitored with excitation at 485 nm and 
emission at 528 nm every 3 minutes for a total of 30 minutes.  
3.3.7 Statistical analysis 
 Experiments were repeated as three independent procedures, with duplicate or 
quadruplicate wells (ROS) averaged prior to statistical analysis, giving a sample size of 
n=3 per group. Results are reported as means with SD to indicate population variability. 
The EC50 were determined by fitting experimental data to the Hill equation using 
MatLab software version 2014a (fitnlm, MathWorks, Inc.). Dose experiments were 
analyzed by one-way ANOVA followed by post hoc T tests using Bonferroni correction 
for multiple comparisons 
3.4 Results 
 PMS and other phenazine analogs can directly oxidize NADH. To determine the 
efficacy of this reaction in our culture model, we measured the content of NAD and 
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NADH. We found a dose dependent decrease in NADH (minimum of 0.167±0.035 
control; 10μM PMS) with EC50 of 33.6±109.7nM (fig. 3-1a) and a reduction of the total 
NAD pool (p=0.0012, fig. 3-1b) with EC50 above 10μM (fig. 3-1c). The NAD
+
/NADH 
ratio, a common measure of redox state increased in a dose dependent manner with 
EC50=3645.2±1.1e
+8
nM. We investigated the production of reactive oxygen species in the 
presence of PMS. Incubation of PMS for 10min increased DCFH2 oxidation with EC50 > 






Figure 3-1 Effect of PMS on cellular NAD and ROS production 




/NADH ratio, and (d) DCFH2 oxidation 







































































 Because the redox state of NAD may influence glucose metabolism and the 
efficiency of ATP production, we measured the effect of PMS on cellular ATP. PMS 
induced a dose-dependent reduction in ATP after15min with EC50 > 3μM (fig. 3-2a). 
This was associated with phosphorylation of ACC with EC50 > 2μM (fig. 3-2b). PDK is 
allosterically activated by NADH and ATP and inhibited by NAD
+
 and AMP (Bowker-
Kinley et al., 1998).To test whether oxidation of NAD or reduction of ATP would inhibit 
PDK, we measured PDH phosphorylation. PMS reduces the phosphorylation of PDH 




Figure 3-2 Effect of PMS on ATP and the phosphorylation of ACC and PDH 
Effect of 15min PMS on cellular (a) ATP, (b) ACC phosphorylation, and (c) PDH phosphorylation (to be 
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 To evaluate effect of redox state on aerobic metabolism, we measured oxygen 
consumption of PMS-treated cells (fig. 3-3). Oxygen consumption rate (OCR) was 
increased by PMS with EC50>1 µM, much higher than the dose required to deplete 
NADH. OCR does increase at PMS doses similar to those that deplete ATP and activate 
AMPK, consistent with a regulated response to ATP depletion. Extracellular acidification 
(ECAR), representative of lactate production and glycolytic metabolism does appear to 
decrease at low PMS concentrations.  C2C12 cells, grown in high glucose conditions 
perform aerobic glycolysis, and the decreased ECAR may represent anaerobic 




Figure 3-3 Effect of PMS on OCR and ECAR 
Effect of PMS on cellular (a) OCR and ECAR (b) OCR and ECAR with injection of 0.5μM rotenone. N= 3 








































































































 In this study, PMS completely oxidized NADH at 200μM in 15min, but OCR, 
ATP depletion, DCFH2 oxidation and the phosphorylation of PDH were significantly 
altered by PMS only above 1μM. We interpret these results as indication that NADH 
oxidation alone is not sufficient to influence PDK activity or oxygen consumption, but 
that ROS production may induce ATP depletion and oxygen consumption at high 
concentrations. 
 The study was based on a model of metabolic control where adenosine 
phosphorylation state strongly influences the activity of glycoylsis enzymes and NAD 
oxidation state strongly influences the disposal of pyruvate by the oxidative or reductive 
pathways. According to this model, conversion of ATP to ADP or AMP would be 
expected to increase glucose transport, PFK activity, and the rate of pyruvate production. 
Reduction in ATP may also increase oxidative disposal of pyruvate by inhibiting 
phosphorylation of PDH. According to this model, it was expected that oxidation of 
NADH would increase the oxidative disposal of pyruvate by inhibiting phosphorylation 
of PDH. Increased oxidation of pyruvate would be expected to increase oxygen 
consumption and decrease lactate production. 
 The O2 consumption could come from inhibition of PDK. Previous in vitro study 
has shown that increasing NAD
+
/NADH ratio reduced PDK4 activity which may increase 
PDH activity and glucose oxidation (Sugden and Holness, 2006). However, we found 
that NADH was depleted at much lower PMS concentration than influences PDH 
phosphorylation.   
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PMS can increase mitochondrial complex I (COXI), complex III (COXIII) activity, 
which would also increase OCR. PMS derivative, methylene blue, has been used 
effectively as an antidote for neurodegenerative disease caused by rotenone (Zhang et al., 
2006). NADH can reduce PMS to PMSH2 (reduced form), whereas cytochrome C 
reoxidizes PMSH2 to PMS (oxidized form). PMS-mediated bypass might reduce ROS 
production by COXI/III, which would be expected near PMS concentration of 40nM. 
However, we found that NADH was depleted at much lower PMS concentrations than 
influence O2 consumption. This suggests that direct shuttling of electrons from NADH to 
cytochrome C, bypassing proton transport by COXI and COXIII, and reducing the 
efficacy of NADH : ATP conversion, does not substantially alter mitochondrial 
respiration in C2C12 cells.  
 PMS might also directly transfer electrons from NADH to molecular oxygen to 
produce superoxide (Van Noorden and Butcher, 1989), and the DCF fluorescence was 
consistent with this mechanism. ROS may inhibit mitochondrial ATP synthesis and 
subsequently activate AMPK (Irrcher et al., 2009). We did find that ATP depletion and 
AMPK activation were induced by PMS in the same concentration range as generated 
ROS. 
 AMPK activation increases glucose uptake, glycolysis and mitochondrial 
respiration in skeletal muscle (Hardie and Ashford, 2014). ROS generated by muscle 
contraction has been shown to facilitate glucose uptake (Chambers et al., 2009), to induce 
mitochondrial biogenesis (Irrcher et al., 2009), and to activate AMPK through liver 
kinase B1 (LKB1) and Calcium/Calmodulin-dependent kinase kinase (CaMMK) 
(Morales-Alamo and Calbet, 2016; Xie et al., 2006). Exercise-induced metabolic 
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challenge is coupled with oxidative challenge resulting in a wide range of adaptive 
responses, but excessive exercise training leading to overproduction of ROS which can 
have detrimental effects on cellular function. To understand redox –sensitive pathway 






Independent AMP and NAD signaling regulate C2C12 
differentiation and metabolic adaptation 
 
4.1  Abstract 
 The balance of ATP production and consumption is reflected in AMP and NAD 
content and has been associated with phenotypic plasticity in striated muscle. Some 
studies have suggested that AMPK-dependent plasticity may be an indirect consequence 
of increased NAD synthesis and SIRT1 activity. The primary goal of this study was to 
assess the interaction of AMP and NAD dependent signaling in adaptation of C2C12 
myotubes. Changes in myotube developmental and metabolic gene expression were 
compared following incubation with AICAR and nicotinamide mononucleotide (NMN) 
to activate AMPK and SIRT1. AICAR showed no effect on NAD pool and nampt 
expression, but significantly reduced histone H3 acetylation, GLUT1, COX2 and MYH3 
expression and reduced myotube density. In contrast, NMN supplementation for 24 hours 
increased NAD pool by 45% but did not reduce histone H3 acetylation nor promote 
mitochondrial gene expression. The combination of AMP and NAD signaling did not 
induce further metabolic adaptation, but NMN ameliorated AICAR-induced myotube 
reduction. We interpret these results as indication that AMP and NAD contribute to 




 Cellular energy status impacts almost all cellular functions. In skeletal muscle 
cells, the rate of ATP turnover increases 100-fold or more during contraction (Schmitz et 
al., 2013), and the cells must accommodate long periods of low metabolic activity 
interspersed with discrete bouts of very high activity. The pattern of this activity seems to 
be very important to the establishment and maintenance of muscle size and phenotype, 
although the mechanism by which activity is transduced to growth remains unclear. 
Two molecules have gained wide recognition as likely transducers of energy metabolism: 
AMP and NAD
+
. Cytoplasmic AMP may rise from nanomolar concentrations at rest to 
micromolar during exercise, while ATP undergoes only fractional declines (Cheetham et 
al., 1986), which makes AMP a very sensitive indicator of ATP balance and AMPK a 
ubiquitous effector of energetic stress. Nicotinamide adenine dinucleotide (NAD) is one 
of the major electron carriers in both oxidative and glycolytic metabolism, and the ratio 
of oxidized NAD
+
 to reduced NADH can be used as a dynamic indicator of metabolite 
balance. In skeletal muscle, this ratio is dominated by the activity of lactate 
dehydrogenase, and the pyruvate / lactate ratio is often used as a proxy for NAD
+ 
/ 
NADH. In cell culture, NAD
+ 
/ NADH declines as media glucose is converted to lactate, 
and is elevated in glucose-restricted media (Fulco et al., 2008). Because NAD
+
 is a 
required substrate for SIRT1, SIRT1 activity might be modulated by the relative 
production of ATP through the oxidative and anaerobic pathways. 
 AMPK and SIRT1 are especially interesting because of their apparent 
interactions.  Although they share several common transcriptional targets, including 
PGC-1α, p53, and FOXO, the cellular consequences of AMPK and/or SIRT1 activation 
74 
 
are highly dependent on cell type and phase. In quiescent satellite cells, SIRT1 reduces 
expression of apoptosis markers (Ryall et al., 2015). In differentiating myoblasts, 
activation of AMPK or SIRT1 represses differentiation and facilitates proliferation (Fulco 
et al., 2008). In mature muscle and fully differentiated myotubes, AMPK and SIRT1 
contribute to mitochondrial biogenesis and expression of a "slow-like" phenotype 
(Gerhart-Hines et al., 2007; Zong et al., 2002). Some evidence suggests that the above-
mentioned transcriptional modifiers or SIRT1 itself may require priming phosphorylation 
by AMPK prior to deacetylation (Canto et al., 2010; McGee and Hargreaves, 2011). A 
number of studies have shown that activation of AMPK increases transcription of nampt, 
the rate-limiting enzyme in the NAD salvage pathway, suggesting that activation of 
AMPK necessarily leads to activation of SIRT1 via increased NAD
+
 or reduced 
nicotinamide (NAM) (Canto et al., 2009; Fulco et al., 2008). 
 These interactions suggest three models for transcriptional regulation by 
cytoplasmic metabolites: an independent model, a nampt model and an AMPK priming 
model. The AMPK-dependent phosphorylation and SIRT1-dependent deacetylation may 
be independent, which would allow additive transcriptional effects from the two 
enzymes. The nampt model suggests that ultimate control of transcription lies in the 
activity of SIRT1 and the availability of NAD
+
 (or depletion of NAM). In this model, 
AMPK participates only as a precursor to elevation of NAD
+
. Finally, if AMPK-
dependent phosphorylation is a necessary antecedent to deacetylation, but not sufficient 
to induce transcriptional activity, then AMPK or SIRT1 activation alone should have 
limited effect, but their co-activation should have strong synergy. 
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 The goal of this study was to evaluate these models in the context of myogenic 
differentiation and energy metabolism. We found that wild type C2C12s do not 
demonstrate the AICAR-induced increase of NAD
+
 observed in PGC-1α-transgenic cells, 
allowing independent manipulation of AMPK activation and NAD
+
 availability to test the 
independence, priority, or synergy of AMP and NAD signaling. Results suggest that no 
single model captures the behavior of all phenotypic markers, but generally support 
independent signaling through the two mechanisms, providing myocytes flexibility to 
respond to diverse metabolic conditions. 
4.3 Materials and Methods 
4.3.1 Materials 
 Antibody for Acetyl-CoA carboxylase (ACC
S79
) and Acetyl-Histone H3 
(Lys9)was purchased from Cell Signaling Technology. C2C12 cells were obtained from 
the American Type Culture Collection (ATCC, Manassas, VA). Dublecco's Modified 
Eagle's Medium (DMEM) was purchased as a powdered mixture (Corning 50-003), 
supplemented with 3.7g/L NaHCO3, and sterilized by 0.2 um filtration. AICAR (Enzo, 
NY, 50mM) and NMN (Sigma-Aldrich, MO, 100mM) were prepared as concentrates in 
ultra-pure water and diluted to working strength in serum free DMEM prior to 
application to cells. 
4.3.2 Cell Culture 
 C2C12 myoblasts were maintained in growth medium (GM, DMEM 
supplemented with 10 % fetal bovine serum (Hyclone), 100 IU/ml penicillin, and 100 
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 on 12-well plates, and allowed to proliferate 2 days to 60-
80% confluence, at which point they were switched to differentiation media (DM, 
DMEM supplemented with 2% horse serum (Hyclone) and antibiotics). Media was 
replenished every 48 h. Cultures generally fused into myotubes within 4 days in DM.  
For treatment, cultures were rinsed twice with serum and antibiotic free DMEM (SFM) 
and incubated 60min prior to application of treatment media. In dose experiments, all 
wells were exposed to NMN for 24 hours. For time-course studies, individual wells were 
exposed to drug for different times, but to minimize manipulation of each plate, the total 
pre-incubation and incubation time was 24 hours for all treatment groups. All cells were 
switched to SFM concurrently, treated with NMN for the indicated time periods, and 
harvested concurrently. This resulted in varying length incubations in SFM equal to the 
difference between 24 hours and the duration of NMN exposure. 
 Following treatment, culture media was collected and boiled for 5 min to 
inactivate enzymatic activity. Media samples were cleared by centrifugation at 16k xg for 
2 min and stored at -20°C. Cultures were rinsed twice with ice cold PBS.  Cultures 
collected for metabolite analysis were harvested by scraping in cold lysis buffer (100mM 
Na2CO3, 20 mM NaHCO3, 20 mM NAM). Cultures collected for ACC phosphorylation 
and citrate synthase activity were harvested in non-denaturing lysis buffer (1% Triton-
X100, 50 mM tris, 300 mM NaCl, 5 mM EDTA) supplemented with protease inhibitors 
(Sigma), 100 mM NaF, and 4 μg/ml NaVO3. Cells were dissociated by trituration and 
sonication for 1 min at room temperature. Lysates were incubated on ice for 10 min and 
cleared by centrifugation at 16k xg for 5 min. Soluble protein concentration was assayed 
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by bicinchronic acid assay (Pierce). Cultures collected for analysis of gene expression 
were harvested in Trizol (Life Technologies) according to the manufacturer's protocol, 
and RNA quantified by UV spectroscopy. 
4.3.3 Cell morphology 
 Micrographs of cultures were obtained at the end of the treatment period under 
phase contrast illumination using 20x objective (Leica). Two random fields were 
captured for each well, covering 13.5 mm
2
. Culture confluence and area density of 
myotubes were determined by point counting.  
4.3.4 Metabolite assays 
 Media lactate was measured by the lactate dehydrogenase method (Pesce et al., 
1975). Samples were reacted in assay buffer (1 M glycine, 200 mM hydrazine, 2 mM 
NAD
+
, pH 9.5) containing 20 U/ml LDH at room temperature for 30 min. Absorbance at 
340 nm was measured, and lactate concentration was calculated using 6.22 as the 
millimolar extinction coefficient for NADH. Values were normalized to lysate protein 
content. 
 Lysate NAD and NADH contents were determined by alcohol dehydrogenase 
(ADH)-diaphorase enzymatic cycling using 10μl of sample and 200ul assay buffer 
(40μg/mL yeast ADH (Alfa Aesar, MA), 0.2% ethyl alcohol, 2mM MgCl2, 0.2 U/ mL 
diaphorase (Innovative Research, MI), 1μM resazurin (Alfa Aesar, MA)). Resorufin 
formation was monitored with excitation at 540 nm and emission at 590 nm every 2 
minutes for a total of 20 minutes. The fluorescence slope was calibrated to standard curve 
and normalized to lysate protein content. For measurement of NADH, 80μl aliquot 
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samples were incubated for 15min at 60°C to destroy NAD
+
 (Wagner and Scott, 1994). 
NAD
+
 was determined by subtracting NADH from NAD. 
4.3.5 Citrate synthase 
 Citrate synthase (CS) activity was measured in whole cell lysates using an assay 
mixture containing 10mM KCl, 100 mM acetyl-CoA, 100 mM 5,5’-dithiobis(2-
nitrobenzoic acid) and 1M oxaloacetate (Sigma-Aldrich, MO) at 22 °C. Enzyme activity 
was monitored by recording the changes in absorbance at 412 nm every 1min over 5 min 
and normalized to protein content. 
4.3.6 Western blot 
 To assay phosphorylation of ACC and acetylation of histone 3, 4 μg soluble 
protein was separated by SDS-PAGE through 7 % acrylamide gels. Protein was 
transferred to nitrocellulose membranes, blocked with 5% nonfat dry milk in Tween-TBS 
(TTBS) and hybridized with phospho-specific antibody. Membranes were rinsed and 
incubated with horseradish peroxidase conjugated secondary antibody (Jackson, 
1:80,000). Bands were detected by enhanced chemiluminescence (Amersham), visualized 
by exposure to radiographic film, and quantified by scanning densitometry. All samples 
from an experiment were run on the same gel, and normalized to the average of that 
experiment’s control samples.  
4.3.7 Gene expression 
 Complimentary DNA was synthesized from 2 µg RNA by reverse transcription 
(Multiscribe) using random hexamers. Amplification reactions contained a target-specific 
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fraction of the reverse transcription product and 250 nM forward and reverse primers in 
Platinum Sybr Green QPCR Supermix (Invitrogen). All samples were run in duplicate. 
Fluorescence was monitored and analyzed in a StepOnePlus real time PCR system 
(Applied Biosystems). Gene expression was normalized by the average of three 
housekeeping genes (GAPDH, RPLP0 and CSNK2A2) and an independent reference 
sample using the relative quantification method. Amplification of specific transcripts was 
initially confirmed by gel and melting curve analysis and routinely validated by melting 
curve profiles at the end of each PCR experiment. Amplification targets were chosen to 
represent differentiation (MYH3, β-actin), oxidative metabolism (COX2, TFAM) and 











β-actin TTCAACACCCCAGCCATGT GTAGATGGGCACAGTGTGGGT 
COX2 CAAGACGCCACATCCCCT ACGGGGTTGTTGATTTCGTC 
CSNK2A2 CCCGAGCTGGGGTAATCA TCTTTTTCTTCACTGGCTTG 
GAPDH AACATCAAATGGGGTGAG GTTGTCATGGATGACCTTG 
GLUT1 GAGGCTTGCTTGTAGAGT GAACTCCTCAATAACCTTCT 
HK1 CACTGCTCACCAGGGCTA ATCCCCCTTTTCTGAGCCGT 
MYH3 CTTGAGCACTGAGCTCTTC TCAGCTGCTCGATCTCTTCA 
nampt AGCACAGTACCATAACGG TCCACGCCATCTCCTTGAAT 
RPLP0 AGATTCGGGATATGCTGTT AAAGCCTGGAAGAAGGAG 




 All values are expressed as means ± S.D. unless otherwise stated. All experiments 
were performed on multiwell tissue culture plates with at least two replicates per 
condition and at least three independent plates, giving sample size (n) of at least 6. Dose-
response experiments were analyzed by two-way, mixed-mode ANOVA in StatView 
(Abacus Software). AICAR * NMN experiments were analyzed by two-way ANOVA in 
R (Team, 2015) using repeated measures blocked by plate. Sample size of 6 with 
repeated measures provides statistical resolution within main effects of 1 S.D. with 87% 
power. The Bonferroni-Dunn correction was used for post hoc T-tests. 
 The independent model predicts that AICAR and NMN may each have 
independent effects, but there should be no interaction. The nampt model predicts that 
AICAR should have no effect, but all signaling should be dependent on NMN. The 
AMPK priming model predicts that there should be strong interaction between AICAR 
and NMN, but that neither will have an effect alone. 
4.4 Results 
 AICAR treatment failed to induce nampt expression or alter the NAD pool, but 
did reduce histone H3 acetylation (fig. 4-1). We have previously found 0.5 mM AICAR 
sufficient to induce maximal ACC phosphorylation within 15 minutes (Hsu and 
Burkholder, 2015), and show here that incubation with 0.5 mM AICAR increased ACC 
phosphorylation to 3.3±0.77 fold of control for 24 hours (p=0.0015). In contrast to 
differentiating myoblasts (Fulco et al., 2008), we did not find induction of nampt 
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expression by AICAR in mature myotubes (p=0.49). Consistent with the absence of 
nampt induction, AICAR did not alter NAD or NADH contents after 24 hour treatment. 
However, AICAR significantly reduced histone H3 acetylation. 
 
 
Figure 4-1 Effect of AICAR and NMN on AMP and NAD signaling 
Effect of AICAR and NMN on (a) ACC phosphorylation (b) nampt mRNA expression (c) lactate 
production rate (d) NAD (e) NADH content and (f) Histone H3 acetylation. N=3 experiments with 
triplicate wells. Bars represent mean ± S.D. Main effect of AICAR p<0.05; Main effect of NMN p<0.05; 
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 Because SIRT1 activity depends on NAD
+
, we determined the concentration of 
NMN to achieve a maximum increase in total NAD. In untreated cells, the NAD pool 
was constant around 4.4±0.3 µmole/g protein over time, with a small accumulation of 
NADH, from 0.08±0.02 µmole/g protein to 0.28±0.07 µmole/g protein (p<0.0001), 
primarily driven by lactate accretion (fig. 4-2). NMN supplementation resulted in a dose- 
and time- dependent increase in total NAD, with maximal increase of 45±4% at 200 µM 
and 8 hours. Similar dose-dependent increases were seen in NAD
+
 and NADH with EC50 
of 15.6 µM and 27.4 µM respectively (Fig -4-2b,c), and the increase in NAD
+
 could be 
resolved as early as 2 hours (Fig. 4-2e). Because NAD and NADH increased similarly, 
the NAD
+
/NADH ratio, a common measure of redox state, was unaffected. NMN was 





Figure 4-2 Effect of NMN supplementation on NAD content 
Effect of 24 hour NMN on cellular (a) NAD (b) NAD+ and (c) NADH content. The time course of cellular 
(d) NAD (e) NAD+ and (f) NADH content during exposure to MNM in SFM. N=3 experiments with 





 The combination of AICAR and NMN altered cellular metabolites independently.  
AICAR treatment decreased lactate production (fig. 4-3c, p=0.014) with no effect on 
NAD, while NMN treatment increased both total and reduced NAD by 40%, with no 
effect on lactate production (fig. 4-1c) or . Examining the signaling expected from these 
changes, AICAR increased ACC phosphorylation to 3.3±0.77 fold of control, while 
NMN had no effect (fig. 4-1b).  The increase in NAD
+
 did not alter H3 acetylation (fig. 
4-1f, p=0.49).  Unexpectedly, AICAR treatment did reduce H3 acetylation (p=0.001), and 
no interaction effect could be resolved (p=0.67). 
 One of the major effects ascribed to AMP/NAD signaling is a PGC-1α mediated 
increase in oxidative metabolism. In our hands, expression of PGC-1α-dependent Tfam 
was unaffected by either AICAR or NMN (fig. 4-3a). Consistent with this, CS activity 
was unaffected by AICAR or NMN (fig. 4-3e). However, two-way ANOVA revealed a 
significant interaction between AICAR and NMN on the expression of mitochondrial 
cytochrome oxidase 2 (COX2, p=0.026,). COX2 expression was reduced by treatment 
with either AICAR or NMN, but the combination was no more effective than either 
substance alone (fig. 4-3b). Changes in oxidative metabolism are often mirrored by 
reciprocal changes in glycolytic metabolism. Although AICAR reduced expression of the 
constitutive glucose transporter, GLUT1, by 19% (fig. 4-3c, p<0.001), we found no effect 
or interaction with NMN. Conversely, NMN, but not AICAR reduced expression of HK1 




Figure 4-3 Effect of AICAR and NMN on metabolic gene expression 
Effect of AICAR and NMN on (a) Tfam (b) COX2 (c) GLUT1 (d) HK1 mRNA expression (e) citrate 
synthase activity. N=6 experiments with duplicate wells for gene expression and N=3 with triplicate wells 
for enzyme activity. Results are shown as mean ± S.D. Main effect of AICAR p<0.05; Main effect of NMN 












































































































































































 AMP and NAD may also influence FOXO and p53 mediated cell survival and 
differentiation (Jones et al., 2005; Motta et al., 2004). Two way ANOVA did reveal an 
interaction between AICAR and NMN on the area fraction of myotube coverage (fig. 4-
4b, p=0.005). Treatment with either AICAR alone or NMN alone resulted in a reduction 
in myotube coverage (44±8% Control; 35±10% AICAR, p=0.006; 37±10% NMN, 
p=0.003), but this was substantially attenuated by the combination of AICAR and NMN 
(41±7%, p=0.16 vs. control). In contrast, AICAR reduced expression of MYH3, the 
earliest of the sarcomeric myosins (fig. 4-4a, p=0.023), while NMN had no effect 
(p=0.75), with no interaction. Treatment with AICAR alone resulted in a significant 
(P<0.0001) reduction on the expression of β-actin, a structural gene that decreases during 
myogenic differentiation (Shimokawa et al., 1998), and this was further enhanced by the 





Figure 4-4 Effect of AICAR and NMN on differentiation gene expression 
Effect of AICAR and NMN on (a) MYH3 mRNA expression (b) myotube coverage (c) β-actin mRNA 
expression. N=6 experiments with duplicate wells for gene expression and triplicate wells for myotube 
coverage. Results are shown as mean ± S.D. Main effect of AICAR p<0.05; Main effect of NMN p<0.05; 




























































































 The goal of this study was to evaluate potential models for transcriptional 
regulation by cytoplasmic metabolites in the context of myogenic differentiation and 
energy metabolism. To examine combinatorial signaling by AMP and NAD, we treated 
C2C12 myotubes with AICAR to activate AMPK and NMN to increase SIRT1 substrate 
availability. NMN did substantially increase NAD
+
 content, but AICAR had no effect on 
either NAD content or oxidation state. AICAR increased ACC phosphorylation and 
reduced H3K9 acetylation, but NMN had no apparent effect on AMPK or SIRT1 activity. 
AICAR reduced expression of COX2, GLUT1, MYH3, and β-actin and reduced myotube 
area coverage. NMN also reduced COX2 expression and myotube area, while increasing 
HK1 expression. Although we did find statistical interaction between AICAR and NMN 
on myotube area fraction and COX2 expression, these interactions resulted from less-
than-additive effect of the two compounds. These results are most consistent with the 
independent signaling model. 
 Cooperative signaling between AMPK and SIRT1 was suggested by their 
common dependence on metabolites associated with ATP metabolism and their shared 
substrates. AMPK is a key energy-sensing kinase, and its activity can be increased by 
energy depletion secondary to many stimuli. NAD
+
 is converted to NADH by GAPDH 
and by the citric acid cycle and back to NAD
+
 by LDH and oxidative phosphorylation. 
NADH rises dramatically during exercise (Sahlin, 1985) and NAD
+
 rises during fasting 
or glucose restriction (Canto and Auwerx, 2009; Fulco et al., 2008), so potentially 
provides distinction between accelerated ATP consumption and limited ATP synthesis. 
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Results of the present study suggest that metabolite accumulation alone is insufficient to 
induce coherent control of either metabolic phenotype or myoblast differentiation. 
Signaling seems to be dominated by AMPK, both at the intermediate level, where it 
increased ACC phosphorylation and decreased H3 acteylation, and at the transcriptional 
level, where it reduced expression of multiple targets.  
 AICAR reduced H3K9 acetylation independent of nampt expression or changes in 
NAD content.  We examined H3K9 acetylation because it is a substrate of the NAD-
dependent sirtuins and the canonical substrate, PGC1a, is expressed at very low levels in 
C2C12.   Some investigators have suggested that the responses to low glucose, fasting, or 
AICAR may result from AMPK-mediated upregulation of nampt and increase cellular 
NAD
+
, providing substrate for SIRT1 (Canto et al., 2010; Fulco et al., 2008), but this 
seems to be strongly dependent on cell phenotype.  Fulco and colleagues (2008) found 
that the inhibition of differentiation in C2C12s depends on the upregulation of nampt, and 
Costford and colleagues (2010) report that AICAR treatment induces nampt in C2C12s 
only during differentiation and not when applied to mature myotubes (Costford et al., 
2010). Canto and colleagues (2010) find AMPK-mediated upregulation of nampt in 
C2C12s only with transgenic PGC-1α. Systemic AICAR increases muscle nampt mRNA 
and protein, but the increase in mRNA is independent of AMPKα2 kinase activity 
(Brandauer et al., 2013). Further, AICAR-induced NAD
+ 
accumulation and PGC-1α 
deacetylation were not blocked by inhibition of nampt even in C2C12s overexpressing 
PGC-1 (Canto et al., 2009). The present results are consistent with a minimal role for 
NAD
+
 availability in the deacetylase activity of C2C12 myotubes with only endogenous 
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PGC1α.  Systems with greater PGC1α, such as mature muscle or transfected cells, may 
become more sensitive to NAD
+
 homeostasis.  
 Energy status, via AMPK, is an important regulator of nutrient uptake and cell 
differentiation (Fulco et al., 2008). AMPK has been shown to induce muscle atrophy and 
protein degradation through FOXO transcriptional activation (Nakashima and Yakabe, 
2007; Romanello et al., 2010). C2C12s retain a sizable population of mononucleated 
cells, and AICAR-induced loss of MYH3 gene expression and reduced myotube area 
fraction (fig. 4-4) are consistent with retarded differentiation of those cells. The onset of 
muscle differentiation is accompanied by the activation of mitochondrial biogenesis. The 
reduction of mitochondrial COX2 gene expression may reflect inhibition of 
differentiation rather than a specific metabolic adaptation.  
 NAD is a coenzyme in energy production and a substrate modulating cellular 
signaling through the PARP1and SIRT1 pathways. In our study, NMN treatment 
increased NAD content and HK1 expression, but differences in NAD account for only 
7% of total HK1 variability. NAD content also affected myotube area and COX2 
expression, similar to the effect of AMPK. Although NMN supplementation raised NAD 
similar to previous studies (Canto et al., 2012), NMN failed to alter CS activity and the 
expression of Tfam, a key factor which governs mitochondrial DNA transcription and 
replication. These results suggest that surplus NAD is not able to enhance mitochondrial 
adaptation, and previous results suggest that C2C12 cells require PGC-1α overexpression 
to unmask substantial SIRT1-dependent mitochondrial plasticity (Gerhart-Hines et al., 
2007). Although dietary NMN or nicotinamide riboside (NR) supplementation improves 
glucose tolerance in high fat diet-induced obesity (Yoshino et al., 2011) and enhances 
92 
 
oxidative metabolism in mice with mitochondrial disorder (Khan et al., 2014), it has no 
effect in normal mice (Canto et al., 2012). Interestingly, nampt gene expression and 
NAD
+
 are significantly lower in the liver and white adipose tissue, but not in skeletal 
muscle after high fat diet-induced obesity (Yoshino et al., 2011). Overexpression of 
nampt in muscle increases NAD
+
 by 50% but fails to increase mitochondrial enzyme 
activity, protein content or gene expression or to protect against metabolic consequences 
of high fat diet (Frederick et al., 2015). These results suggest that NAD pool in skeletal 
muscle is not sufficient to induce metabolic remodeling, but requires an additional 
stressor.  
 The present results are most consistent with the independent signaling model. In 
our hands, nampt was not upregulated, and NAD was not increased by AICAR treatment. 
With the exception of Tfam, all markers were affected by either AICAR or NMN 
treatment. The limited interactions, seen only in COX2 expression and myotube area 
fraction, are consistent with saturation, that is: either AICAR or NMN treatment alone 
induces a maximal effect. In some models, the response to AICAR or metabolic stress 
depends on AMPK-mediated upregulation of nampt and can be mimicked by 
pharmacological increase in NAD (Canto et al., 2009; Canto et al., 2010; Fulco et al., 
2008). These models suggest that NAD
+
-dependent signaling is necessary, and possibly 
sufficient for adaptation. However, the most dramatic effects of NAD
+
 are observed 
during differentiation of myoblasts (Fulco et al., 2008), in myotubes overexpressing 
PGC-1α (Canto et al., 2009) , or in mature muscle interacting with other tissues. The 
effect of SIRT1 disruption, in C2C12s with only endogenous PGC-1α, is quite modest 
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 Although the rate of ATP turnover during high intensity exercise is more than 100 
times higher than that at rest, the level of ATP in skeletal muscle is relatively stable 
(Cheetham et al., 1986). This is because skeletal muscle not only possesses fast and 
efficient mechanisms of ATP resynthesis, but also has ability to switch rapidly from an 
aerobic to an anaerobic energy system during high intensity exercise. The activation of 
glycolysis and mitochondrial respiration are related to the elevation of glucose metabolite 
concentrations (Brown, 1992; Sahlin et al., 1990). Substantial control is exerted by 
allosteric feedback, particularly of ATP and NAD. Substrate-level inhibition, in which 
the build-up of reaction products slows the reaction rate by mass action, contributes 
strongly to balance among the steps of glycolysis and mitochondrial respiration. This 
project is based on the conceptual model that ATP depletion causes the accumulation of 
AMP and NADH, in which AMP regulates glycolysis, NADH determines the aerobic and 
anaerobic glucose distribution and the AMP/NAD interaction signaling serves as a 
mechanism for metabolic adaptation. The overall hypothesis in this study is that the 
distribution of glucose depends on the AMP and NAD generated during energetic stress, 
and the AMPK-SIRT1 interactions contribute to the adaptation.  
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 The objective of the first study was to investigate the role of AMPK and p38 in 
glucose metabolism during ATP depletion and to determine whether AMP-mediated 
activation of AMPK is sufficient to induce p38 activation and maximize glucose 
transport. We found rotenone poison causes transient ATP depletion and p38 
phosphorylation with increased lactate production, but p38 inhibition had no effect on 
ATP recovery. Glucose restriction and dors blocked rotenone-induced p38 
phosphorylation following rotenone treatment, but AICAR failed to activate p38. The 
conclusion from this study is that metabolic stress activates both AMPK and p38, but p38 
required extracellular glucose, in addition to AMPK. This illustrates that simple AMP 
signaling is not sufficient to completely define the cellular response. 
 The objective of the second study was to investigate the role of NADH in glucose 
distribution and to determine whether NADH oxidation increases mitochondrial 
respiration through PDH phosphorylation. We found that PMS completely oxidized 
NADH at low dose, but oxygen consumption, ATP depletion, ROS production and the 
phosphorylation of PDH were significantly induced by PMS only at high dose. The 
conclusion from this study is that NADH oxidation alone is not sufficient to define the 
balance of reductive and oxidative metabolism of pyruvate, but ROS-AMPK signaling 
may be involved in stimulating oxygen consumption. 
 The objective of the third study was to investigate the role of AMP and NAD 
signaling for transcriptional regulation in the context of myogenic differentiation and 
metabolism. We found AICAR reduced H3K9 acetylation, COX2 and MYH3 mRNA 
expression, but failed to increase NAMPT mRNA expression, or NAD content. In 
contrast, NMN increased NAD content similar to previous studies (Canto et al., 2012), 
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but failed to alter H3K9 acetylation, CS activity and the expression of Tfam. The 
conclusion from this study is that energetic stress-induced metabolic adaptation may 
depend on AMP signaling, but NAD is dispensable.  
 The overall conclusion of this project is that C2C12 myotubes, with few 
mitochondria and with only endogenous PGC-1α, are not sensitive to NAD signaling. In 
these cells, the metabolism and distribution of glucose depend on AMP signaling. 
Furthermore, AMP mediated AMPK activation contributes to metabolic adaptation, but 
NAD mediated SIRT1 signaling is dispensable. This contrasts with studies in whole 
muscle or in myotubes overexpressing PGC-1α, which showed that NAD signaling is 
able to influence metabolic adaptation via SIRT1 signaling. These findings suggest that 
glucose metabolism is not controlled by single molecule. Other molecules may represent 





Figure 5-1 Revised model in C2C12 myotubes 
In C2C12 myotubes, low mitochondrial content minimizes the influence of NAD-mediated signaling, both 
in the control of pyruvate disposal and long-term plasticity. High glucose availability and low expression of 




































Mitochondrial complex dysfunction in skeletal muscle has been implicated in type 
2 diabetes (Kelley et al., 2002). NADH supplied from glucose and fatty acid is the main 
substrate for ETC. Mitochondrial complex I dysfunction inhibits the oxidation of lipid 
and glucose and causes the accumulation of NADH. Low dose of PMS is able to oxidize 
NADH and acts as an electron carrier that replaces the damaged mitochondrial complex. 
Phenothiazine compounds, such as methylene blue, may provide a useful treatment for 
mitochondrial dysfunction in diabetes. However, in this project high dose of PMS inhibits 
ATP synthesis which may cause muscle fatigue and stimulate ROS production. The 
phenothiazine compounds have been used for the treatment of malaria, cyanide and 
carbon monoxide poisoning. Careful dosing and post-treatment monitoring are highly 
recommended.  
Exercise is a powerful intervention for the treatment of many different diseases 
(Pedersen and Saltin, 2015). Caloric restriction and endurance exercise activate AMPK 
and SIRT1 which are thought to increase mitochondrial biogenesis. In contrast to this 
idea, the combination of AICAR and NMN to directly activate AMPK and SIRT1 had no 
effect on Tfam mRNA expression. Instead, AICAR significantly reduced COX2 and 
MYH3 gene expression suggesting that AMPK activation may inhibit differentiation and 
myotube formation. It is consistent with the report that AMPK inhibits protein synthesis 
by inactivating the mammalian target of rapamycin (mTOR) signaling pathway. Given 
the potentially negative effects of AMPK on muscle growth, those who want to increase 
muscle mass and muscle strength should avoid high volume and long duration training. In 
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contrast, low nutrient state may enhance exercise-induced AMP and NAD signaling 
which may amplify metabolic adaptation. This is supported by the recent studies that 
repeated endurance training with low muscle glycogen availability results in greater 
endurance adaptation (Bartlett et al., 2015; Hawley and Morton, 2014).  
Previous studies have shown that low intensity muscle contraction with blood 
flow restriction training enhances muscle strength and muscle mass without increasing 
the incidence of muscle damage (Loenneke et al., 2014; Slysz et al., 2015). However, the 
cellular mechanisms underlying the muscle hypertrophy induced by blood flow 
restriction are unknown. Muscle hypoxia resulting from impaired blood flow could 
evaluate HIF-1α, the major transcription factor triggered by hypoxia (Semenza, 2000). 
Blood flow restriction limits NADH oxidation and lowers NAD
+
 due to the decrease of 
oxygen delivery. The inactivation of SIRT1 and SIRT2 increases HIF-1α transcriptional 
activity by preventing the hydroxylation of HIf-1α (Seo et al., 2015) or increasing the 
recruitment of p300 (Lim et al., 2010). Muscle contraction also increases HIF-1α activity 
through AMPK-mediated phosphorylation (Lee et al., 2003). It is possible that the 
activation of AMPK and inactivation of SIRT1 in muscle contraction with blood flow 
restriction augment muscle hypertrophy. 
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5.3 Future Directions 
The first study found that p38 activation by rotenone required extracellular 
glucose. Growth factor, UV light, inflammatory cytokine or oxidative stress activates p38 
through MKK3/6 canonical pathway (Cuadrado and Nebreda, 2010), but the mechanism 
in which hyperglycemia activates p38 is less clear. The activation of p38 in 
hyperglycemia may results in many pathological conditions (Igarashi et al., 1999). To 
characterize the mechanisms by which elevation of glucose levels activates p38 signaling 
may provide useful therapies to prevent complications in diabetes. 
 In this project, we are able to boost NAD content through NMN supplementation, 
but there is no change in H3K9 acetylation.  NAD can be synthesized in nucleus, cytosol, 
and mitochondria via salvaging pathway, but the regulation of NAD biosynthesis by 
NAD
+
-consuming signaling is still not clear. Sirtuins act in different compartments and 
NAD concentrations differ among these cellular compartments. It is possible that NAD-
consuming signaling selectively depends on the compartmentalization of NAD. 
Mitochondrial NAD concentration is usually higher than that in the cytosol (Alano et al., 
2007). To understand how NAD is shuttled among these organelles and how NAD pool is 
maintained in the individual compartments may elucidate the NAD-sirtuin signaling in 
glucose metabolism.  
 In this project, AMPK is clearly an important signaling mediator in glycolysis and 
metabolic adaptation. This is supported by the fact that World Anti-Doping Agency has 
included AICAR in the prohibited list since 2009 (WADA, 2016). Since SIRT1 may 
improve mitochondrial biogenesis in skeletal muscle whether NAD precursors can 
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enhance endurance training and should be added to prohibited list are not clear (Thevis 
and Schanzer, 2016). Further human research is warranted to see the effect of NMN or 
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